# Autodesk timeline entity: /record/autodesk.md id: ent_autodesk ## undated - undated | state_of_incorporation | DE | valid | [clm_60ACD6E111FE](/claim/clm_60ACD6E111FE.md) - undated | ticker | ADSK | valid | [clm_773BF2BDBA81](/claim/clm_773BF2BDBA81.md) - undated | sic_industry | Services-Prepackaged Software (7372) | valid | [clm_86B46DD09300](/claim/clm_86B46DD09300.md) - undated | fiscal_year_end | 01-31 | valid | [clm_A93EA125084B](/claim/clm_A93EA125084B.md) - undated | cik | 0000769397 | valid | [clm_AD8F8027331B](/claim/clm_AD8F8027331B.md) - undated | listed_on | Nasdaq | valid | [clm_BB7C1D351403](/claim/clm_BB7C1D351403.md) - undated | member_of | Business Software Alliance | unverified | [clm_50D2D7DE7E83](/claim/clm_50D2D7DE7E83.md) - undated | legal_form | public company | unverified | [clm_8811B5BB852A](/claim/clm_8811B5BB852A.md) - undated | country | United States | valid | [clm_8D51B8E7CF4E](/claim/clm_8D51B8E7CF4E.md) - undated | website | https://www.autodesk.com/ | unverified | [clm_E9A21753CE7B](/claim/clm_E9A21753CE7B.md) ## 1994 - 1994-09-14 | registrant_name | Autodesk, Inc. | valid | [clm_7A0DE46D8030](/claim/clm_7A0DE46D8030.md) ## 2007 - 2007-01-31 to 2008-01-31 | cash_and_equivalents | 665,900,000 United States dollar | superseded | [clm_2078A9032533](/claim/clm_2078A9032533.md) - 2007-01-31 to 2008-01-31 | total_equity | 1,115,000,000 United States dollar | superseded | [clm_7FFC15C56671](/claim/clm_7FFC15C56671.md) ## 2008 - 2008-01-31 to 2008-04-30 | cash_and_equivalents | 917,900,000 United States dollar | superseded | [clm_18C6FB1D7370](/claim/clm_18C6FB1D7370.md) - 2008-01-31 to 2009-01-31 | total_equity | 1,230,500,000 United States dollar | superseded | [clm_2FA26661B815](/claim/clm_2FA26661B815.md) - 2008-01-31 to 2009-01-31 | revenue | 2,171,900,000 United States dollar | superseded | [clm_6F126B0089E0](/claim/clm_6F126B0089E0.md) - 2008-01-31 to 2009-01-31 | operating_income | 445,600,000 United States dollar | superseded | [clm_9855317D6713](/claim/clm_9855317D6713.md) - 2008-01-31 to 2009-01-31 | research_and_development | 490,500,000 United States dollar | superseded | [clm_A6C18B58F09C](/claim/clm_A6C18B58F09C.md) - 2008-01-31 to 2009-01-31 | net_income | 356,200,000 United States dollar | superseded | [clm_B6DEDEAC0073](/claim/clm_B6DEDEAC0073.md) - 2008-04-30 to 2008-07-31 | cash_and_equivalents | 909,100,000 United States dollar | superseded | [clm_33CDC846F35C](/claim/clm_33CDC846F35C.md) - 2008-04-30 to 2008-07-31 | quarterly_net_income | 94,600,000 United States dollar | superseded | [clm_839A29DBE661](/claim/clm_839A29DBE661.md) - 2008-04-30 to 2008-07-31 | quarterly_revenue | 598,800,000 United States dollar | superseded | [clm_BDF4F8E7F1DF](/claim/clm_BDF4F8E7F1DF.md) - 2008-04-30 to 2008-07-31 | quarterly_operating_income | 119,900,000 United States dollar | superseded | [clm_C5964EAC7EB5](/claim/clm_C5964EAC7EB5.md) - 2008-04-30 to 2008-07-31 | quarterly_research_and_development | 145,600,000 United States dollar | superseded | [clm_F1DF842D0634](/claim/clm_F1DF842D0634.md) - 2008-07-31 to 2008-10-31 | quarterly_revenue | 619,500,000 United States dollar | superseded | [clm_77EC05EB78D7](/claim/clm_77EC05EB78D7.md) - 2008-07-31 to 2008-10-31 | cash_and_equivalents | 929,600,000 United States dollar | superseded | [clm_AACF37B15AA7](/claim/clm_AACF37B15AA7.md) - 2008-07-31 to 2008-10-31 | quarterly_net_income | 89,800,000 United States dollar | superseded | [clm_B033573A17A4](/claim/clm_B033573A17A4.md) - 2008-07-31 to 2008-10-31 | quarterly_research_and_development | 154,800,000 United States dollar | superseded | [clm_DAC724E565CC](/claim/clm_DAC724E565CC.md) - 2008-07-31 to 2008-10-31 | quarterly_operating_income | 118,800,000 United States dollar | superseded | [clm_E05546CDEE4F](/claim/clm_E05546CDEE4F.md) - 2008-10-31 to 2009-01-31 | cash_and_equivalents | 796,400,000 United States dollar | superseded | [clm_0BC97FAA8CD7](/claim/clm_0BC97FAA8CD7.md) - 2008-10-31 to 2009-04-30 | quarterly_research_and_development | 137,000,000 United States dollar | superseded | [clm_0E7323A65578](/claim/clm_0E7323A65578.md) - 2008-10-31 to 2009-04-30 | quarterly_revenue | 607,100,000 United States dollar | superseded | [clm_4887914CA5E7](/claim/clm_4887914CA5E7.md) - 2008-10-31 to 2009-04-30 | quarterly_operating_income | 139,600,000 United States dollar | superseded | [clm_884404D0D1E3](/claim/clm_884404D0D1E3.md) - 2008-10-31 to 2009-04-30 | quarterly_net_income | 104,500,000 United States dollar | superseded | [clm_9710396E6DEA](/claim/clm_9710396E6DEA.md) ## 2009 - 2009-01-31 to 2009-04-30 | total_equity | 1,310,700,000 United States dollar | superseded | [clm_0EEB0BB49539](/claim/clm_0EEB0BB49539.md) - 2009-01-31 to 2010-01-31 | operating_income | 244,500,000 United States dollar | superseded | [clm_280F07A9AC50](/claim/clm_280F07A9AC50.md) - 2009-01-31 to 2010-01-31 | net_income | 183,600,000 United States dollar | superseded | [clm_2C72EEFBCA0C](/claim/clm_2C72EEFBCA0C.md) - 2009-01-31 to 2009-04-30 | cash_and_equivalents | 917,600,000 United States dollar | superseded | [clm_678A71DD2A28](/claim/clm_678A71DD2A28.md) - 2009-01-31 to 2010-01-31 | research_and_development | 576,100,000 United States dollar | superseded | [clm_9C6BE8789EB3](/claim/clm_9C6BE8789EB3.md) - 2009-01-31 to 2010-01-31 | revenue | 2,315,200,000 United States dollar | superseded | [clm_9E02205CF422](/claim/clm_9E02205CF422.md) - 2009-01-31 to 2009-04-30 | total_assets | 2,420,700,000 United States dollar | superseded | [clm_B7B3D615B71C](/claim/clm_B7B3D615B71C.md) - 2009-04-16 | x_username | autodesk | unverified | [clm_AC55F1DA1034](/claim/clm_AC55F1DA1034.md) - 2009-04-30 to 2009-07-31 | cash_and_equivalents | 880,500,000 United States dollar | superseded | [clm_0F9ADE0F1A3E](/claim/clm_0F9ADE0F1A3E.md) - 2009-04-30 to 2009-07-31 | quarterly_operating_income | -19,400,000 United States dollar | superseded | [clm_473065DAC55D](/claim/clm_473065DAC55D.md) - 2009-04-30 to 2009-07-31 | quarterly_net_income | -32,100,000 United States dollar | superseded | [clm_668088EAF973](/claim/clm_668088EAF973.md) - 2009-04-30 to 2009-07-31 | quarterly_research_and_development | 124,100,000 United States dollar | superseded | [clm_7C69F9EF3A3C](/claim/clm_7C69F9EF3A3C.md) - 2009-04-30 to 2009-08-21 | shares_outstanding | 228,408,965 shares | superseded | [clm_83281CC2F3DB](/claim/clm_83281CC2F3DB.md) - 2009-04-30 to 2009-07-31 | quarterly_revenue | 425,800,000 United States dollar | superseded | [clm_891A117DDAC4](/claim/clm_891A117DDAC4.md) - 2009-04-30 to 2009-07-31 | total_equity | 1,328,500,000 United States dollar | superseded | [clm_A3C2F815DF7C](/claim/clm_A3C2F815DF7C.md) - 2009-04-30 to 2009-07-31 | total_assets | 2,269,500,000 United States dollar | superseded | [clm_B6B7D1BFA3C9](/claim/clm_B6B7D1BFA3C9.md) - 2009-07-31 to 2009-10-31 | quarterly_research_and_development | 109,800,000 United States dollar | superseded | [clm_03A552341022](/claim/clm_03A552341022.md) - 2009-07-31 to 2009-10-31 | total_equity | 1,385,100,000 United States dollar | superseded | [clm_09C9D627D1AB](/claim/clm_09C9D627D1AB.md) - 2009-07-31 to 2009-10-31 | quarterly_revenue | 414,900,000 United States dollar | superseded | [clm_3A0425DDB051](/claim/clm_3A0425DDB051.md) - 2009-07-31 to 2009-10-31 | quarterly_operating_income | 2,700,000 United States dollar | superseded | [clm_61E06C4F22EC](/claim/clm_61E06C4F22EC.md) - 2009-07-31 to 2009-10-31 | cash_and_equivalents | 668,500,000 United States dollar | superseded | [clm_794A677685EE](/claim/clm_794A677685EE.md) - 2009-07-31 to 2009-10-31 | total_assets | 2,311,100,000 United States dollar | superseded | [clm_B6FB3D0D14A9](/claim/clm_B6FB3D0D14A9.md) - 2009-07-31 to 2009-10-31 | quarterly_net_income | 10,500,000 United States dollar | superseded | [clm_DF1FC2BD658B](/claim/clm_DF1FC2BD658B.md) - 2009-08-21 to 2009-11-30 | shares_outstanding | 229,732,680 shares | superseded | [clm_E9DE7EC33FD0](/claim/clm_E9DE7EC33FD0.md) - 2009-10-31 to 2010-04-30 | quarterly_revenue | 416,900,000 United States dollar | superseded | [clm_4C2071EE9DF8](/claim/clm_4C2071EE9DF8.md) - 2009-10-31 to 2010-01-31 | total_equity | 1,431,700,000 United States dollar | superseded | [clm_70B11ADF14C9](/claim/clm_70B11ADF14C9.md) - 2009-10-31 to 2010-04-30 | quarterly_operating_income | 26,300,000 United States dollar | superseded | [clm_9A0D4B5D6247](/claim/clm_9A0D4B5D6247.md) - 2009-10-31 to 2010-01-31 | cash_and_equivalents | 698,500,000 United States dollar | superseded | [clm_9A16C66BF21B](/claim/clm_9A16C66BF21B.md) - 2009-10-31 to 2010-01-31 | total_assets | 2,315,400,000 United States dollar | superseded | [clm_A826D6B613CB](/claim/clm_A826D6B613CB.md) - 2009-10-31 to 2010-04-30 | quarterly_research_and_development | 109,300,000 United States dollar | superseded | [clm_F1D04028CB4C](/claim/clm_F1D04028CB4C.md) - 2009-10-31 to 2010-04-30 | quarterly_net_income | 29,500,000 United States dollar | superseded | [clm_FC34B781E200](/claim/clm_FC34B781E200.md) - 2009-11-30 to 2010-03-12 | shares_outstanding | 229,719,532 shares | superseded | [clm_CB2C648DDAA1](/claim/clm_CB2C648DDAA1.md) ## 2010 - 2010-01-31 to 2010-04-30 | total_equity | 1,473,500,000 United States dollar | superseded | [clm_388445F975D2](/claim/clm_388445F975D2.md) - 2010-01-31 to 2011-01-31 | operating_income | 65,600,000 United States dollar | superseded | [clm_3F483E4CB53A](/claim/clm_3F483E4CB53A.md) - 2010-01-31 to 2010-12-31 | revenue | 1,713,700,000 United States dollar | superseded | [clm_7955B74A69DC](/claim/clm_7955B74A69DC.md) - 2010-01-31 to 2011-01-31 | net_income | 58,000,000 United States dollar | superseded | [clm_948FD8A3F229](/claim/clm_948FD8A3F229.md) - 2010-01-31 to 2011-01-31 | research_and_development | 457,500,000 United States dollar | superseded | [clm_B8CBF0F06508](/claim/clm_B8CBF0F06508.md) - 2010-01-31 to 2010-04-30 | total_assets | 2,447,200,000 United States dollar | superseded | [clm_D2B24577B593](/claim/clm_D2B24577B593.md) - 2010-01-31 to 2010-04-30 | cash_and_equivalents | 838,700,000 United States dollar | superseded | [clm_DC851129F54B](/claim/clm_DC851129F54B.md) - 2010-03-12 to 2010-05-28 | shares_outstanding | 229,300,000 shares | superseded | [clm_5FA136F36279](/claim/clm_5FA136F36279.md) - 2010-04-30 to 2010-07-31 | quarterly_net_income | 36,900,000 United States dollar | superseded | [clm_040F29D28E6F](/claim/clm_040F29D28E6F.md) - 2010-04-30 to 2010-07-31 | total_equity | 1,514,100,000 United States dollar | superseded | [clm_23DA3FD3E741](/claim/clm_23DA3FD3E741.md) - 2010-04-30 to 2010-07-31 | quarterly_operating_income | 50,800,000 United States dollar | superseded | [clm_7290B79527B9](/claim/clm_7290B79527B9.md) - 2010-04-30 to 2010-07-31 | total_assets | 2,501,700,000 United States dollar | superseded | [clm_772726561026](/claim/clm_772726561026.md) - 2010-04-30 to 2010-07-31 | cash_and_equivalents | 938,100,000 United States dollar | superseded | [clm_8E434B7020A7](/claim/clm_8E434B7020A7.md) - 2010-04-30 to 2010-07-31 | quarterly_revenue | 474,600,000 United States dollar | superseded | [clm_9ABDAD16E3EF](/claim/clm_9ABDAD16E3EF.md) - 2010-04-30 to 2010-07-31 | quarterly_research_and_development | 127,200,000 United States dollar | superseded | [clm_BBECF557055E](/claim/clm_BBECF557055E.md) - 2010-05-28 to 2010-08-24 | shares_outstanding | 229,463,291 shares | superseded | [clm_65B5281F26A6](/claim/clm_65B5281F26A6.md) - 2010-07-31 to 2010-10-31 | total_assets | 2,525,000,000 United States dollar | superseded | [clm_276567B583C0](/claim/clm_276567B583C0.md) - 2010-07-31 to 2010-10-31 | quarterly_research_and_development | 119,300,000 United States dollar | superseded | [clm_33B132B8A53E](/claim/clm_33B132B8A53E.md) - 2010-07-31 to 2010-10-31 | quarterly_operating_income | 79,800,000 United States dollar | superseded | [clm_4291CA6A241F](/claim/clm_4291CA6A241F.md) - 2010-07-31 to 2010-10-31 | total_equity | 1,525,800,000 United States dollar | superseded | [clm_467B01148EE4](/claim/clm_467B01148EE4.md) - 2010-07-31 to 2010-10-31 | quarterly_net_income | 59,900,000 United States dollar | superseded | [clm_85609ABDF3F7](/claim/clm_85609ABDF3F7.md) - 2010-07-31 to 2010-10-31 | cash_and_equivalents | 850,000,000 United States dollar | superseded | [clm_DA2C49ECBCBC](/claim/clm_DA2C49ECBCBC.md) - 2010-07-31 to 2010-10-31 | quarterly_revenue | 472,800,000 United States dollar | superseded | [clm_E9EE1EA6807B](/claim/clm_E9EE1EA6807B.md) - 2010-08-24 to 2010-11-30 | shares_outstanding | 227,283,469 shares | superseded | [clm_3B60B95F7289](/claim/clm_3B60B95F7289.md) - 2010-10-31 to 2011-01-31 | cash_and_equivalents | 904,300,000 United States dollar | superseded | [clm_3FFAC6F125F3](/claim/clm_3FFAC6F125F3.md) - 2010-10-31 to 2011-01-31 | total_assets | 2,581,100,000 United States dollar | superseded | [clm_6C03BED0264A](/claim/clm_6C03BED0264A.md) - 2010-10-31 to 2011-04-30 | quarterly_research_and_development | 122,800,000 United States dollar | superseded | [clm_7E53DCB3B811](/claim/clm_7E53DCB3B811.md) - 2010-10-31 to 2011-01-31 | total_equity | 1,556,100,000 United States dollar | superseded | [clm_880453A0EBE3](/claim/clm_880453A0EBE3.md) - 2010-10-31 to 2011-04-30 | quarterly_operating_income | 69,200,000 United States dollar | superseded | [clm_A104D19856A6](/claim/clm_A104D19856A6.md) - 2010-10-31 to 2011-04-30 | quarterly_revenue | 476,700,000 United States dollar | superseded | [clm_C8630EF3F37A](/claim/clm_C8630EF3F37A.md) - 2010-10-31 to 2011-04-30 | quarterly_net_income | 53,600,000 United States dollar | superseded | [clm_CEA0EE9D396A](/claim/clm_CEA0EE9D396A.md) - 2010-11-30 to 2011-03-11 | shares_outstanding | 227,394,939 shares | superseded | [clm_3F59641F495A](/claim/clm_3F59641F495A.md) - 2010-12-31 to 2011-01-31 | revenue | 1,710,000,000 United States dollar | superseded | [clm_8DB7619AA2F2](/claim/clm_8DB7619AA2F2.md) ## 2011 - 2011-01-31 to 2012-01-31 | research_and_development | 496,200,000 United States dollar | superseded | [clm_2C49BD52868E](/claim/clm_2C49BD52868E.md) - 2011-01-31 to 2012-01-31 | revenue | 1,951,800,000 United States dollar | superseded | [clm_35A14F6FA607](/claim/clm_35A14F6FA607.md) - 2011-01-31 to 2011-04-30 | total_assets | 2,787,600,000 United States dollar | superseded | [clm_84C5346D42CF](/claim/clm_84C5346D42CF.md) - 2011-01-31 to 2011-04-30 | total_equity | 1,609,300,000 United States dollar | superseded | [clm_852EE1F68FD3](/claim/clm_852EE1F68FD3.md) - 2011-01-31 to 2011-04-30 | cash_and_equivalents | 1,075,100,000 United States dollar | superseded | [clm_E1EBA6CEDFCB](/claim/clm_E1EBA6CEDFCB.md) - 2011-01-31 to 2012-01-31 | operating_income | 271,400,000 United States dollar | superseded | [clm_E95A9EE0314E](/claim/clm_E95A9EE0314E.md) - 2011-01-31 to 2012-01-31 | net_income | 212,000,000 United States dollar | superseded | [clm_EA892B71F3CA](/claim/clm_EA892B71F3CA.md) - 2011-03-11 to 2011-05-27 | shares_outstanding | 227,900,000 shares | superseded | [clm_CA86B1512683](/claim/clm_CA86B1512683.md) - 2011-04-30 to 2011-07-31 | quarterly_net_income | 69,300,000 United States dollar | superseded | [clm_2BECB619A3D2](/claim/clm_2BECB619A3D2.md) - 2011-04-30 to 2011-07-31 | quarterly_research_and_development | 136,600,000 United States dollar | superseded | [clm_3EA8A21CA7CD](/claim/clm_3EA8A21CA7CD.md) - 2011-04-30 to 2011-07-31 | quarterly_revenue | 528,300,000 United States dollar | superseded | [clm_488F986C8D60](/claim/clm_488F986C8D60.md) - 2011-04-30 to 2011-07-31 | cash_and_equivalents | 1,091,400,000 United States dollar | superseded | [clm_8642F9A6552B](/claim/clm_8642F9A6552B.md) - 2011-04-30 to 2011-07-31 | quarterly_operating_income | 78,600,000 United States dollar | superseded | [clm_B4843EB112D0](/claim/clm_B4843EB112D0.md) - 2011-04-30 to 2011-07-31 | total_assets | 2,902,200,000 United States dollar | superseded | [clm_C58D2FD24C9C](/claim/clm_C58D2FD24C9C.md) - 2011-04-30 to 2011-07-31 | total_equity | 1,751,200,000 United States dollar | superseded | [clm_EBD955FC0F3A](/claim/clm_EBD955FC0F3A.md) - 2011-05-27 to 2011-08-26 | shares_outstanding | 230,954,185 shares | superseded | [clm_50BC1FEF06F9](/claim/clm_50BC1FEF06F9.md) - 2011-07-31 to 2011-10-31 | quarterly_net_income | 71,200,000 United States dollar | superseded | [clm_1759691836A2](/claim/clm_1759691836A2.md) - 2011-07-31 to 2011-10-31 | quarterly_research_and_development | 139,200,000 United States dollar | superseded | [clm_221E906AEBC0](/claim/clm_221E906AEBC0.md) - 2011-07-31 to 2011-10-31 | total_equity | 1,789,100,000 United States dollar | superseded | [clm_637361EB2A57](/claim/clm_637361EB2A57.md) - 2011-07-31 to 2011-10-31 | quarterly_revenue | 546,300,000 United States dollar | superseded | [clm_759A7D941C6C](/claim/clm_759A7D941C6C.md) - 2011-07-31 to 2011-10-31 | cash_and_equivalents | 1,131,500,000 United States dollar | superseded | [clm_82363E01F81E](/claim/clm_82363E01F81E.md) - 2011-07-31 to 2011-10-31 | total_assets | 2,973,700,000 United States dollar | superseded | [clm_B078FE21F4D6](/claim/clm_B078FE21F4D6.md) - 2011-07-31 to 2011-10-31 | quarterly_operating_income | 95,000,000 United States dollar | superseded | [clm_F2BD48F0B954](/claim/clm_F2BD48F0B954.md) - 2011-08-26 to 2011-11-30 | shares_outstanding | 228,824,634 shares | superseded | [clm_04BD509349EA](/claim/clm_04BD509349EA.md) - 2011-10-31 to 2012-01-31 | total_equity | 1,827,500,000 United States dollar | superseded | [clm_0A0F58F42A64](/claim/clm_0A0F58F42A64.md) - 2011-10-31 to 2012-01-31 | total_assets | 3,005,000,000 United States dollar | superseded | [clm_2470C229BD18](/claim/clm_2470C229BD18.md) - 2011-10-31 to 2012-04-30 | quarterly_operating_income | 90,200,000 United States dollar | superseded | [clm_37FB38FA86B5](/claim/clm_37FB38FA86B5.md) - 2011-10-31 to 2012-04-30 | quarterly_revenue | 548,600,000 United States dollar | superseded | [clm_68439B2711E4](/claim/clm_68439B2711E4.md) - 2011-10-31 to 2012-01-31 | cash_and_equivalents | 1,103,300,000 United States dollar | superseded | [clm_BB5F9EE9D65F](/claim/clm_BB5F9EE9D65F.md) - 2011-10-31 to 2012-04-30 | quarterly_research_and_development | 141,200,000 United States dollar | superseded | [clm_BBB687EF4D50](/claim/clm_BBB687EF4D50.md) - 2011-10-31 to 2012-04-30 | quarterly_net_income | 72,800,000 United States dollar | superseded | [clm_FDA8AE48D33B](/claim/clm_FDA8AE48D33B.md) - 2011-11-30 to 2012-02-29 | shares_outstanding | 226,800,000 shares | superseded | [clm_78EE10AC655A](/claim/clm_78EE10AC655A.md) ## 2012 - 2012-01-31 to 2013-01-31 | operating_income | 355,600,000 United States dollar | superseded | [clm_24ABAB9926EF](/claim/clm_24ABAB9926EF.md) - 2012-01-31 to 2012-04-30 | total_assets | 3,227,800,000 United States dollar | superseded | [clm_492757E76E2A](/claim/clm_492757E76E2A.md) - 2012-01-31 to 2012-04-30 | total_equity | 1,882,900,000 United States dollar | superseded | [clm_4F03F4BB95CE](/claim/clm_4F03F4BB95CE.md) - 2012-01-31 to 2012-04-30 | cash_and_equivalents | 1,156,900,000 United States dollar | superseded | [clm_58BF45EA4680](/claim/clm_58BF45EA4680.md) - 2012-01-31 to 2013-01-31 | research_and_development | 566,500,000 United States dollar | superseded | [clm_88DA1695E245](/claim/clm_88DA1695E245.md) - 2012-01-31 to 2013-01-31 | revenue | 2,215,600,000 United States dollar | superseded | [clm_C25EFAE2A068](/claim/clm_C25EFAE2A068.md) - 2012-01-31 to 2013-01-31 | net_income | 285,300,000 United States dollar | superseded | [clm_F000FE72E647](/claim/clm_F000FE72E647.md) - 2012-02-29 to 2012-05-25 | shares_outstanding | 227,300,000 shares | superseded | [clm_09ED60F91070](/claim/clm_09ED60F91070.md) - 2012-04-30 to 2012-07-31 | cash_and_equivalents | 1,074,500,000 United States dollar | superseded | [clm_1D841151671E](/claim/clm_1D841151671E.md) - 2012-04-30 to 2012-07-31 | quarterly_operating_income | 94,000,000 United States dollar | superseded | [clm_3D64425FACA0](/claim/clm_3D64425FACA0.md) - 2012-04-30 to 2012-07-31 | quarterly_research_and_development | 152,700,000 United States dollar | superseded | [clm_AE1AF3E558D5](/claim/clm_AE1AF3E558D5.md) - 2012-04-30 to 2012-07-31 | total_equity | 2,045,300,000 United States dollar | superseded | [clm_BD0B458B8A2B](/claim/clm_BD0B458B8A2B.md) - 2012-04-30 to 2012-07-31 | quarterly_net_income | 78,900,000 United States dollar | superseded | [clm_C4A7E3BB011F](/claim/clm_C4A7E3BB011F.md) - 2012-04-30 to 2012-07-31 | quarterly_revenue | 588,600,000 United States dollar | superseded | [clm_D7AFCECDA8AB](/claim/clm_D7AFCECDA8AB.md) - 2012-04-30 to 2012-07-31 | total_assets | 3,317,000,000 United States dollar | superseded | [clm_FAFF9103B8D3](/claim/clm_FAFF9103B8D3.md) - 2012-05-25 to 2012-08-31 | shares_outstanding | 229,800,000 shares | superseded | [clm_633D174ADA5E](/claim/clm_633D174ADA5E.md) - 2012-07-31 to 2012-10-31 | total_equity | 2,051,300,000 United States dollar | superseded | [clm_05EB7D3E07EA](/claim/clm_05EB7D3E07EA.md) - 2012-07-31 to 2012-10-31 | cash_and_equivalents | 930,200,000 United States dollar | superseded | [clm_50FD4EF8660D](/claim/clm_50FD4EF8660D.md) - 2012-07-31 to 2012-10-31 | total_assets | 3,375,900,000 United States dollar | superseded | [clm_7394C06E77D4](/claim/clm_7394C06E77D4.md) - 2012-07-31 to 2012-10-31 | quarterly_research_and_development | 144,900,000 United States dollar | superseded | [clm_8AEE160D4048](/claim/clm_8AEE160D4048.md) - 2012-07-31 to 2012-10-31 | quarterly_net_income | 64,600,000 United States dollar | superseded | [clm_9D4586AED49E](/claim/clm_9D4586AED49E.md) - 2012-07-31 to 2012-10-31 | quarterly_operating_income | 92,900,000 United States dollar | superseded | [clm_F9E01B644491](/claim/clm_F9E01B644491.md) - 2012-07-31 to 2012-10-31 | quarterly_revenue | 568,700,000 United States dollar | superseded | [clm_FB3AE12E4814](/claim/clm_FB3AE12E4814.md) - 2012-08-31 to 2012-11-30 | shares_outstanding | 226,900,000 shares | superseded | [clm_934C644640AA](/claim/clm_934C644640AA.md) - 2012-10-31 to 2013-04-30 | quarterly_revenue | 548,000,000 United States dollar | superseded | [clm_075D97D2B182](/claim/clm_075D97D2B182.md) - 2012-10-31 to 2013-04-30 | quarterly_net_income | 29,400,000 United States dollar | superseded | [clm_9FC112849C64](/claim/clm_9FC112849C64.md) - 2012-10-31 to 2013-04-30 | quarterly_research_and_development | 153,000,000 United States dollar | superseded | [clm_C44C1C7781E5](/claim/clm_C44C1C7781E5.md) - 2012-10-31 to 2013-04-30 | quarterly_operating_income | 34,400,000 United States dollar | superseded | [clm_CAF70A6FC017](/claim/clm_CAF70A6FC017.md) - 2012-10-31 to 2013-01-31 | total_assets | 3,429,200,000 United States dollar | superseded | [clm_E699888F850D](/claim/clm_E699888F850D.md) - 2012-10-31 to 2013-01-31 | total_equity | 2,017,900,000 United States dollar | superseded | [clm_EF96CCB8957D](/claim/clm_EF96CCB8957D.md) - 2012-10-31 to 2013-01-31 | cash_and_equivalents | 827,000,000 United States dollar | superseded | [clm_F9233043A389](/claim/clm_F9233043A389.md) - 2012-11-30 to 2013-02-28 | shares_outstanding | 224,700,000 shares | superseded | [clm_46B66FB4AE49](/claim/clm_46B66FB4AE49.md) ## 2013 - 2013-01-31 to 2014-01-31 | operating_income | 305,900,000 United States dollar | superseded | [clm_55928E5D4032](/claim/clm_55928E5D4032.md) - 2013-01-31 to 2014-01-31 | research_and_development | 600,000,000 United States dollar | superseded | [clm_5BEB72D81CAB](/claim/clm_5BEB72D81CAB.md) - 2013-01-31 to 2014-01-31 | revenue | 2,312,200,000 United States dollar | superseded | [clm_A25DC7FB0DDB](/claim/clm_A25DC7FB0DDB.md) - 2013-01-31 to 2013-04-30 | total_equity | 2,043,200,000 United States dollar | superseded | [clm_AF88D5496E43](/claim/clm_AF88D5496E43.md) - 2013-01-31 to 2013-04-30 | total_assets | 4,308,400,000 United States dollar | superseded | [clm_B3A975F66EC4](/claim/clm_B3A975F66EC4.md) - 2013-01-31 to 2014-01-31 | net_income | 247,400,000 United States dollar | superseded | [clm_BAE5CED7D103](/claim/clm_BAE5CED7D103.md) - 2013-01-31 to 2013-04-30 | cash_and_equivalents | 1,612,200,000 United States dollar | superseded | [clm_CE6369A8DB60](/claim/clm_CE6369A8DB60.md) - 2013-02-28 to 2013-05-31 | shares_outstanding | 223,800,000 shares | superseded | [clm_28EA7F0C66A7](/claim/clm_28EA7F0C66A7.md) - 2013-04-30 to 2013-07-31 | quarterly_research_and_development | 150,800,000 United States dollar | superseded | [clm_14088C783231](/claim/clm_14088C783231.md) - 2013-04-30 to 2013-07-31 | quarterly_operating_income | 81,400,000 United States dollar | superseded | [clm_88175AECFF21](/claim/clm_88175AECFF21.md) - 2013-04-30 to 2013-07-31 | total_equity | 2,084,500,000 United States dollar | superseded | [clm_AB41B4CE99BC](/claim/clm_AB41B4CE99BC.md) - 2013-04-30 to 2013-07-31 | quarterly_revenue | 570,400,000 United States dollar | superseded | [clm_D1FB12AAB43E](/claim/clm_D1FB12AAB43E.md) - 2013-04-30 to 2013-07-31 | total_assets | 4,289,700,000 United States dollar | superseded | [clm_E1DE914A924C](/claim/clm_E1DE914A924C.md) - 2013-04-30 to 2013-07-31 | quarterly_net_income | 55,600,000 United States dollar | superseded | [clm_E2CF75412792](/claim/clm_E2CF75412792.md) - 2013-04-30 to 2013-07-31 | cash_and_equivalents | 1,655,800,000 United States dollar | superseded | [clm_E92B771DBF22](/claim/clm_E92B771DBF22.md) - 2013-05-31 to 2013-08-27 | shares_outstanding | 224,800,000 shares | superseded | [clm_9954A92CB8E7](/claim/clm_9954A92CB8E7.md) - 2013-07-31 to 2013-10-31 | quarterly_net_income | 61,700,000 United States dollar | superseded | [clm_135F7D8B751F](/claim/clm_135F7D8B751F.md) - 2013-07-31 to 2013-10-31 | total_assets | 4,223,300,000 United States dollar | superseded | [clm_2F52F885E12D](/claim/clm_2F52F885E12D.md) - 2013-07-31 to 2013-10-31 | total_equity | 2,051,100,000 United States dollar | superseded | [clm_36499F9F141A](/claim/clm_36499F9F141A.md) - 2013-07-31 to 2013-10-31 | quarterly_revenue | 561,700,000 United States dollar | superseded | [clm_42DE3EC6E318](/claim/clm_42DE3EC6E318.md) - 2013-07-31 to 2013-10-31 | quarterly_research_and_development | 148,900,000 United States dollar | superseded | [clm_700C6A843D7D](/claim/clm_700C6A843D7D.md) - 2013-07-31 to 2013-10-31 | cash_and_equivalents | 1,401,000,000 United States dollar | superseded | [clm_CCDE1861516F](/claim/clm_CCDE1861516F.md) - 2013-07-31 to 2013-10-31 | quarterly_operating_income | 83,600,000 United States dollar | superseded | [clm_EF79BF71E153](/claim/clm_EF79BF71E153.md) - 2013-08-27 to 2013-11-29 | shares_outstanding | 223,000,000 shares | superseded | [clm_14EED31F8720](/claim/clm_14EED31F8720.md) - 2013-10-31 to 2014-04-30 | quarterly_research_and_development | 149,000,000 United States dollar | superseded | [clm_1A40BE97B763](/claim/clm_1A40BE97B763.md) - 2013-10-31 to 2014-04-30 | quarterly_operating_income | 68,100,000 United States dollar | superseded | [clm_38B6AFC257E4](/claim/clm_38B6AFC257E4.md) - 2013-10-31 to 2014-04-30 | quarterly_revenue | 555,200,000 United States dollar | superseded | [clm_790082CC8405](/claim/clm_790082CC8405.md) - 2013-10-31 to 2014-01-31 | total_assets | 4,321,500,000 United States dollar | superseded | [clm_9265D59FC38E](/claim/clm_9265D59FC38E.md) - 2013-10-31 to 2014-04-30 | quarterly_net_income | 57,600,000 United States dollar | superseded | [clm_9D99F0DE2395](/claim/clm_9D99F0DE2395.md) - 2013-10-31 to 2014-01-31 | total_equity | 2,161,900,000 United States dollar | superseded | [clm_A68E2FCC849E](/claim/clm_A68E2FCC849E.md) - 2013-10-31 to 2014-01-31 | cash_and_equivalents | 1,473,400,000 United States dollar | superseded | [clm_E14C5B369E1E](/claim/clm_E14C5B369E1E.md) - 2013-11-29 to 2014-02-28 | shares_outstanding | 225,600,000 shares | superseded | [clm_63EC2F59932D](/claim/clm_63EC2F59932D.md) ## 2014 - 2014-01-31 to 2014-04-30 | cash_and_equivalents | 1,853,000,000 United States dollar | superseded | [clm_2C4F0117B4AF](/claim/clm_2C4F0117B4AF.md) - 2014-01-31 to 2014-04-30 | total_equity | 2,261,500,000 United States dollar | superseded | [clm_636CEDEBFBF0](/claim/clm_636CEDEBFBF0.md) - 2014-01-31 to 2015-01-31 | research_and_development | 611,100,000 United States dollar | superseded | [clm_662B97BAA42A](/claim/clm_662B97BAA42A.md) - 2014-01-31 to 2015-01-31 | net_income | 228,800,000 United States dollar | superseded | [clm_99220E541F00](/claim/clm_99220E541F00.md) - 2014-01-31 to 2014-04-30 | total_assets | 4,595,000,000 United States dollar | superseded | [clm_9E46B4830868](/claim/clm_9E46B4830868.md) - 2014-01-31 to 2015-01-31 | revenue | 2,273,900,000 United States dollar | superseded | [clm_A50351D3A3BD](/claim/clm_A50351D3A3BD.md) - 2014-01-31 to 2015-01-31 | operating_income | 284,800,000 United States dollar | superseded | [clm_D07E23CC3789](/claim/clm_D07E23CC3789.md) - 2014-02-28 to 2014-05-29 | shares_outstanding | 227,185,041 shares | superseded | [clm_67C3773E0E0C](/claim/clm_67C3773E0E0C.md) - 2014-04-30 to 2014-07-31 | cash_and_equivalents | 1,609,600,000 United States dollar | superseded | [clm_0B514907C40F](/claim/clm_0B514907C40F.md) - 2014-04-30 to 2014-07-31 | quarterly_net_income | 28,300,000 United States dollar | superseded | [clm_1FCA98AC7742](/claim/clm_1FCA98AC7742.md) - 2014-04-30 to 2014-07-31 | quarterly_research_and_development | 170,500,000 United States dollar | superseded | [clm_55F6ADCF253A](/claim/clm_55F6ADCF253A.md) - 2014-04-30 to 2014-07-31 | total_equity | 2,288,700,000 United States dollar | superseded | [clm_6A8676430149](/claim/clm_6A8676430149.md) - 2014-04-30 to 2014-07-31 | quarterly_revenue | 592,500,000 United States dollar | superseded | [clm_871F3EF1F5E0](/claim/clm_871F3EF1F5E0.md) - 2014-04-30 to 2014-07-31 | quarterly_operating_income | 42,200,000 United States dollar | superseded | [clm_927372F5419D](/claim/clm_927372F5419D.md) - 2014-04-30 to 2014-07-31 | total_assets | 4,648,600,000 United States dollar | superseded | [clm_D3F256CBD311](/claim/clm_D3F256CBD311.md) - 2014-05-29 to 2014-08-27 | shares_outstanding | 227,866,880 shares | superseded | [clm_8A68C42A2D43](/claim/clm_8A68C42A2D43.md) - 2014-07-31 to 2014-10-31 | quarterly_net_income | 31,300,000 United States dollar | superseded | [clm_1BA76557B158](/claim/clm_1BA76557B158.md) - 2014-07-31 to 2014-10-31 | quarterly_research_and_development | 179,300,000 United States dollar | superseded | [clm_4554FF68094C](/claim/clm_4554FF68094C.md) - 2014-07-31 to 2014-10-31 | quarterly_operating_income | 49,900,000 United States dollar | superseded | [clm_66E8C94DEC74](/claim/clm_66E8C94DEC74.md) - 2014-07-31 to 2014-10-31 | cash_and_equivalents | 1,323,100,000 United States dollar | superseded | [clm_68B922A081E5](/claim/clm_68B922A081E5.md) - 2014-07-31 to 2014-10-31 | quarterly_revenue | 637,100,000 United States dollar | superseded | [clm_7570D973BB87](/claim/clm_7570D973BB87.md) - 2014-07-31 to 2014-10-31 | total_equity | 2,283,400,000 United States dollar | superseded | [clm_75CE442977AF](/claim/clm_75CE442977AF.md) - 2014-07-31 to 2014-10-31 | total_assets | 4,703,400,000 United States dollar | superseded | [clm_B5DCA999F0C8](/claim/clm_B5DCA999F0C8.md) - 2014-08-27 to 2014-12-02 | shares_outstanding | 227,236,453 shares | superseded | [clm_03592D6873E6](/claim/clm_03592D6873E6.md) - 2014-10-31 to 2015-01-31 | total_equity | 2,268,500,000 United States dollar | superseded | [clm_15D0D583C7AF](/claim/clm_15D0D583C7AF.md) - 2014-10-31 to 2015-04-30 | quarterly_net_income | 10,700,000 United States dollar | superseded | [clm_2191697D4508](/claim/clm_2191697D4508.md) - 2014-10-31 to 2015-04-30 | quarterly_revenue | 618,000,000 United States dollar | superseded | [clm_8E573A17F4FE](/claim/clm_8E573A17F4FE.md) - 2014-10-31 to 2015-01-31 | cash_and_equivalents | 1,345,000,000 United States dollar | superseded | [clm_D21FD36AC51E](/claim/clm_D21FD36AC51E.md) - 2014-10-31 to 2015-01-31 | total_assets | 4,736,800,000 United States dollar | superseded | [clm_D5BE218254CA](/claim/clm_D5BE218254CA.md) - 2014-10-31 to 2015-04-30 | quarterly_research_and_development | 183,900,000 United States dollar | superseded | [clm_E0BA97A5349C](/claim/clm_E0BA97A5349C.md) - 2014-10-31 to 2015-04-30 | quarterly_operating_income | 14,600,000 United States dollar | superseded | [clm_E49A44FB798D](/claim/clm_E49A44FB798D.md) - 2014-12-02 to 2015-02-28 | shares_outstanding | 227,520,504 shares | superseded | [clm_827BA0A656D8](/claim/clm_827BA0A656D8.md) ## 2015 - 2015-01-31 to 2015-04-30 | cash_and_equivalents | 1,410,600,000 United States dollar | superseded | [clm_36EFCBA8BC4D](/claim/clm_36EFCBA8BC4D.md) - 2015-01-31 to 2016-01-31 | net_income | 81,800,000 United States dollar | superseded | [clm_4B913BEEC574](/claim/clm_4B913BEEC574.md) - 2015-01-31 to 2016-01-31 | research_and_development | 725,200,000 United States dollar | superseded | [clm_4E3C21561E07](/claim/clm_4E3C21561E07.md) - 2015-01-31 to 2016-01-31 | operating_income | 120,700,000 United States dollar | superseded | [clm_55F8CACB3AF9](/claim/clm_55F8CACB3AF9.md) - 2015-01-31 to 2016-01-31 | revenue | 2,512,200,000 United States dollar | superseded | [clm_A79BB89BD129](/claim/clm_A79BB89BD129.md) - 2015-01-31 to 2015-04-30 | total_assets | 4,913,800,000 United States dollar | superseded | [clm_DA286E2A600C](/claim/clm_DA286E2A600C.md) - 2015-01-31 to 2015-04-30 | total_equity | 2,219,200,000 United States dollar | superseded | [clm_FF46689397FC](/claim/clm_FF46689397FC.md) - 2015-02-28 to 2015-05-22 | shares_outstanding | 227,204,316 shares | superseded | [clm_C3A4DD0CA0F1](/claim/clm_C3A4DD0CA0F1.md) - 2015-04-30 to 2015-07-31 | quarterly_research_and_development | 194,500,000 United States dollar | superseded | [clm_19B5263D1336](/claim/clm_19B5263D1336.md) - 2015-04-30 to 2015-07-31 | cash_and_equivalents | 1,182,700,000 United States dollar | superseded | [clm_5AD5C8FB9532](/claim/clm_5AD5C8FB9532.md) - 2015-04-30 to 2015-07-31 | total_assets | 4,775,900,000 United States dollar | superseded | [clm_66A4FF2844F1](/claim/clm_66A4FF2844F1.md) - 2015-04-30 to 2015-07-31 | total_equity | 2,224,400,000 United States dollar | superseded | [clm_854C827E1EF8](/claim/clm_854C827E1EF8.md) - 2015-04-30 to 2015-07-31 | quarterly_revenue | 646,500,000 United States dollar | superseded | [clm_A0646445F3B7](/claim/clm_A0646445F3B7.md) - 2015-04-30 to 2015-07-31 | quarterly_operating_income | 21,500,000 United States dollar | superseded | [clm_BACF351E5B93](/claim/clm_BACF351E5B93.md) - 2015-04-30 to 2015-07-31 | quarterly_net_income | 19,100,000 United States dollar | superseded | [clm_C2D18A7873ED](/claim/clm_C2D18A7873ED.md) - 2015-05-22 to 2015-08-26 | shares_outstanding | 227,652,233 shares | superseded | [clm_E9CE00DB3714](/claim/clm_E9CE00DB3714.md) - 2015-07-31 to 2015-10-31 | cash_and_equivalents | 1,473,100,000 United States dollar | superseded | [clm_2EBF4901BEEF](/claim/clm_2EBF4901BEEF.md) - 2015-07-31 to 2015-10-31 | total_assets | 5,341,800,000 United States dollar | superseded | [clm_4434D8B6A4BF](/claim/clm_4434D8B6A4BF.md) - 2015-07-31 to 2015-10-31 | quarterly_operating_income | 4,300,000 United States dollar | superseded | [clm_5B936DD148A4](/claim/clm_5B936DD148A4.md) - 2015-07-31 to 2015-10-31 | quarterly_net_income | -235,500,000 United States dollar | superseded | [clm_71CCA63B331B](/claim/clm_71CCA63B331B.md) - 2015-07-31 to 2015-10-31 | quarterly_research_and_development | 193,100,000 United States dollar | superseded | [clm_A6A6BAD43E99](/claim/clm_A6A6BAD43E99.md) - 2015-07-31 to 2015-10-31 | total_equity | 1,902,100,000 United States dollar | superseded | [clm_D3E7E1556398](/claim/clm_D3E7E1556398.md) - 2015-07-31 to 2015-10-31 | quarterly_revenue | 609,500,000 United States dollar | superseded | [clm_F4E02D9CF7A3](/claim/clm_F4E02D9CF7A3.md) - 2015-08-26 to 2015-11-30 | shares_outstanding | 226,199,054 shares | superseded | [clm_707370690F13](/claim/clm_707370690F13.md) - 2015-10-31 to 2016-04-30 | quarterly_net_income | -43,800,000 United States dollar | superseded | [clm_035D86356BA4](/claim/clm_035D86356BA4.md) - 2015-10-31 to 2016-04-30 | quarterly_operating_income | -14,800,000 United States dollar | superseded | [clm_118E027A3888](/claim/clm_118E027A3888.md) - 2015-10-31 to 2016-01-31 | cash_and_equivalents | 1,337,500,000 United States dollar | superseded | [clm_4E96424D34AC](/claim/clm_4E96424D34AC.md) - 2015-10-31 to 2016-04-30 | quarterly_research_and_development | 197,900,000 United States dollar | superseded | [clm_7094374050FB](/claim/clm_7094374050FB.md) - 2015-10-31 to 2016-01-31 | total_assets | 5,220,000,000 United States dollar | superseded | [clm_932CCFB6F0F5](/claim/clm_932CCFB6F0F5.md) - 2015-10-31 to 2016-04-30 | quarterly_revenue | 599,800,000 United States dollar | superseded | [clm_CE05CEFB7624](/claim/clm_CE05CEFB7624.md) - 2015-10-31 to 2016-01-31 | total_equity | 1,733,100,000 United States dollar | superseded | [clm_D9ACA9EA074F](/claim/clm_D9ACA9EA074F.md) - 2015-11-30 to 2016-03-09 | shares_outstanding | 225,323,161 shares | superseded | [clm_224C4A9C081E](/claim/clm_224C4A9C081E.md) ## 2016 - 2016-01-31 to 2017-01-31 | net_income | -330,500,000 United States dollar | superseded | [clm_31231F23888F](/claim/clm_31231F23888F.md) - 2016-01-31 to 2017-01-31 | revenue | 2,504,100,000 United States dollar | superseded | [clm_31DCB9E1C26B](/claim/clm_31DCB9E1C26B.md) - 2016-01-31 to 2017-01-31 | operating_income | 1,300,000 United States dollar | superseded | [clm_44CC0AA0BFA8](/claim/clm_44CC0AA0BFA8.md) - 2016-01-31 to 2016-04-30 | total_assets | 5,515,300,000 United States dollar | superseded | [clm_60510A0E7F54](/claim/clm_60510A0E7F54.md) - 2016-01-31 to 2016-04-30 | cash_and_equivalents | 1,353,000,000 United States dollar | superseded | [clm_DC1C54946EC7](/claim/clm_DC1C54946EC7.md) - 2016-01-31 to 2016-04-30 | total_equity | 1,619,600,000 United States dollar | superseded | [clm_E7DFE356965E](/claim/clm_E7DFE356965E.md) - 2016-01-31 to 2017-01-31 | research_and_development | 790,000,000 United States dollar | superseded | [clm_F6C9D7A6596B](/claim/clm_F6C9D7A6596B.md) - 2016-03-09 to 2016-05-31 | shares_outstanding | 224,493,192 shares | superseded | [clm_46F84ACFBDE5](/claim/clm_46F84ACFBDE5.md) - 2016-04-30 to 2016-07-31 | quarterly_net_income | -173,000,000 United States dollar | superseded | [clm_2BD5EA057CCB](/claim/clm_2BD5EA057CCB.md) - 2016-04-30 to 2016-07-31 | quarterly_revenue | 511,900,000 United States dollar | superseded | [clm_3BE028D86BA3](/claim/clm_3BE028D86BA3.md) - 2016-04-30 to 2016-07-31 | total_equity | 1,435,900,000 United States dollar | superseded | [clm_87287299C3D1](/claim/clm_87287299C3D1.md) - 2016-04-30 to 2016-07-31 | quarterly_operating_income | -155,000,000 United States dollar | superseded | [clm_8C4D940E20C8](/claim/clm_8C4D940E20C8.md) - 2016-04-30 to 2016-07-31 | total_assets | 5,205,600,000 United States dollar | superseded | [clm_B9ECF7964086](/claim/clm_B9ECF7964086.md) - 2016-04-30 to 2016-07-31 | cash_and_equivalents | 1,223,400,000 United States dollar | superseded | [clm_BA44AB7EA482](/claim/clm_BA44AB7EA482.md) - 2016-04-30 to 2016-07-31 | quarterly_research_and_development | 195,500,000 United States dollar | superseded | [clm_C71F70A6F42C](/claim/clm_C71F70A6F42C.md) - 2016-05-31 to 2016-08-23 | shares_outstanding | 224,656,057 shares | superseded | [clm_8CF32890C532](/claim/clm_8CF32890C532.md) - 2016-07-31 to 2016-10-31 | quarterly_operating_income | -62,900,000 United States dollar | superseded | [clm_4D5B00A3F02B](/claim/clm_4D5B00A3F02B.md) - 2016-07-31 to 2016-10-31 | quarterly_net_income | -98,200,000 United States dollar | superseded | [clm_5BAECE9B47E7](/claim/clm_5BAECE9B47E7.md) - 2016-07-31 to 2016-10-31 | total_assets | 5,047,400,000 United States dollar | superseded | [clm_6898C85C0A6D](/claim/clm_6898C85C0A6D.md) - 2016-07-31 to 2016-10-31 | quarterly_revenue | 550,700,000 United States dollar | superseded | [clm_81CEE61A5CC1](/claim/clm_81CEE61A5CC1.md) - 2016-07-31 to 2016-10-31 | total_equity | 1,331,700,000 United States dollar | superseded | [clm_9CF9CAC6EF50](/claim/clm_9CF9CAC6EF50.md) - 2016-07-31 to 2016-10-31 | quarterly_research_and_development | 193,000,000 United States dollar | superseded | [clm_AE4F0F52FCAE](/claim/clm_AE4F0F52FCAE.md) - 2016-07-31 to 2016-10-31 | cash_and_equivalents | 1,467,300,000 United States dollar | superseded | [clm_EF6A79F66ED1](/claim/clm_EF6A79F66ED1.md) - 2016-08-23 to 2016-11-22 | shares_outstanding | 221,892,961 shares | superseded | [clm_95AC3A84C20A](/claim/clm_95AC3A84C20A.md) - 2016-10-31 to 2017-01-31 | cash_and_equivalents | 1,436,500,000 United States dollar | superseded | [clm_0FD36F1F9326](/claim/clm_0FD36F1F9326.md) - 2016-10-31 to 2017-01-31 | total_assets | 4,829,200,000 United States dollar | superseded | [clm_14D950301C78](/claim/clm_14D950301C78.md) - 2016-10-31 to 2017-04-30 | quarterly_revenue | 489,600,000 United States dollar | superseded | [clm_2ECB6F81BE5D](/claim/clm_2ECB6F81BE5D.md) - 2016-10-31 to 2017-04-30 | quarterly_research_and_development | 192,600,000 United States dollar | superseded | [clm_89B041136180](/claim/clm_89B041136180.md) - 2016-10-31 to 2017-04-30 | quarterly_operating_income | -119,900,000 United States dollar | superseded | [clm_E21D2C7C9164](/claim/clm_E21D2C7C9164.md) - 2016-10-31 to 2017-04-30 | quarterly_net_income | -142,800,000 United States dollar | superseded | [clm_E35A9FA702BD](/claim/clm_E35A9FA702BD.md) - 2016-10-31 to 2017-01-31 | total_equity | 1,060,600,000 United States dollar | superseded | [clm_F625A635858E](/claim/clm_F625A635858E.md) - 2016-11-22 to 2017-03-10 | shares_outstanding | 222,556,352 shares | superseded | [clm_0B528B6D35DD](/claim/clm_0B528B6D35DD.md) ## 2017 - 2017-01-31 to 2017-04-30 | total_assets | 4,798,100,000 United States dollar | superseded | [clm_054EBB849A51](/claim/clm_054EBB849A51.md) - 2017-01-31 to 2018-01-31 | research_and_development | 766,100,000 United States dollar | superseded | [clm_0C8531828857](/claim/clm_0C8531828857.md) - 2017-01-31 to 2018-01-31 | operating_income | -499,600,000 United States dollar | superseded | [clm_7E44D483011D](/claim/clm_7E44D483011D.md) - 2017-01-31 to 2017-04-30 | total_equity | 733,600,000 United States dollar | superseded | [clm_A3750C74CC84](/claim/clm_A3750C74CC84.md) - 2017-01-31 to 2018-01-31 | net_income | -582,100,000 United States dollar | superseded | [clm_C9ABF39500CB](/claim/clm_C9ABF39500CB.md) - 2017-01-31 to 2017-04-30 | cash_and_equivalents | 1,213,100,000 United States dollar | superseded | [clm_CBE8EC1AAAE9](/claim/clm_CBE8EC1AAAE9.md) - 2017-01-31 to 2018-01-31 | revenue | 2,031,000,000 United States dollar | superseded | [clm_FF5EEE57DF0F](/claim/clm_FF5EEE57DF0F.md) - 2017-03-10 to 2017-05-25 | shares_outstanding | 220,849,268 shares | superseded | [clm_E3B6D9FB3CC8](/claim/clm_E3B6D9FB3CC8.md) - 2017-04-30 to 2017-07-31 | quarterly_revenue | 485,700,000 United States dollar | superseded | [clm_181C417C1B3B](/claim/clm_181C417C1B3B.md) - 2017-04-30 to 2017-07-31 | total_equity | 508,100,000 United States dollar | superseded | [clm_2B44F9EFFA6D](/claim/clm_2B44F9EFFA6D.md) - 2017-04-30 to 2017-07-31 | quarterly_net_income | -129,600,000 United States dollar | superseded | [clm_834FDF1A1733](/claim/clm_834FDF1A1733.md) - 2017-04-30 to 2017-07-31 | cash_and_equivalents | 1,340,200,000 United States dollar | superseded | [clm_ACF72B645478](/claim/clm_ACF72B645478.md) - 2017-04-30 to 2017-07-31 | total_assets | 4,431,400,000 United States dollar | superseded | [clm_BCECF95CA600](/claim/clm_BCECF95CA600.md) - 2017-04-30 to 2017-07-31 | quarterly_operating_income | -119,600,000 United States dollar | superseded | [clm_BD99C7DE5544](/claim/clm_BD99C7DE5544.md) - 2017-04-30 to 2017-07-31 | quarterly_research_and_development | 187,700,000 United States dollar | superseded | [clm_C74085F3782F](/claim/clm_C74085F3782F.md) - 2017-05-25 to 2017-08-24 | shares_outstanding | 220,391,696 shares | superseded | [clm_F86FBC3232F5](/claim/clm_F86FBC3232F5.md) - 2017-07-31 to 2017-10-31 | total_equity | 315,500,000 United States dollar | superseded | [clm_1DA9A6358C6F](/claim/clm_1DA9A6358C6F.md) - 2017-07-31 to 2017-10-31 | quarterly_research_and_development | 193,800,000 United States dollar | superseded | [clm_3FF85770E8D7](/claim/clm_3FF85770E8D7.md) - 2017-07-31 to 2017-10-31 | quarterly_revenue | 501,800,000 United States dollar | superseded | [clm_566A7D475962](/claim/clm_566A7D475962.md) - 2017-07-31 to 2017-10-31 | quarterly_operating_income | -107,600,000 United States dollar | superseded | [clm_7F75139A09ED](/claim/clm_7F75139A09ED.md) - 2017-07-31 to 2017-10-31 | total_assets | 4,354,000,000 United States dollar | superseded | [clm_83DC52362BDE](/claim/clm_83DC52362BDE.md) - 2017-07-31 to 2017-10-31 | quarterly_net_income | -144,000,000 United States dollar | superseded | [clm_8A4BCD72D864](/claim/clm_8A4BCD72D864.md) - 2017-07-31 to 2017-10-31 | cash_and_equivalents | 1,174,100,000 United States dollar | superseded | [clm_BA36872FEC69](/claim/clm_BA36872FEC69.md) - 2017-08-24 to 2017-11-30 | shares_outstanding | 219,192,248 shares | superseded | [clm_D0DCE13EC4D0](/claim/clm_D0DCE13EC4D0.md) - 2017-10-31 to 2018-04-30 | quarterly_net_income | -119,800,000 United States dollar | superseded | [clm_23F64F65FA84](/claim/clm_23F64F65FA84.md) - 2017-10-31 to 2018-04-30 | quarterly_research_and_development | 191,800,000 United States dollar | superseded | [clm_8D317CDFA8EB](/claim/clm_8D317CDFA8EB.md) - 2017-10-31 to 2018-01-31 | total_assets | 4,152,000,000 United States dollar | superseded | [clm_9CB204E6E76A](/claim/clm_9CB204E6E76A.md) - 2017-10-31 to 2018-04-30 | quarterly_revenue | 515,300,000 United States dollar | superseded | [clm_9F740BA63E98](/claim/clm_9F740BA63E98.md) - 2017-10-31 to 2018-01-31 | cash_and_equivalents | 1,025,200,000 United States dollar | superseded | [clm_A74376DA00B1](/claim/clm_A74376DA00B1.md) - 2017-10-31 to 2018-01-31 | total_equity | 107,300,000 United States dollar | superseded | [clm_B8A690ACEC1F](/claim/clm_B8A690ACEC1F.md) - 2017-10-31 to 2018-04-30 | quarterly_operating_income | -100,000,000 United States dollar | superseded | [clm_EFBD705356E8](/claim/clm_EFBD705356E8.md) - 2017-11-30 to 2018-03-12 | shares_outstanding | 220,266,822 shares | superseded | [clm_C9DEC59283FB](/claim/clm_C9DEC59283FB.md) ## 2018 - 2018-01-31 to 2018-04-30 | total_equity | -256,000,000 United States dollar | superseded | [clm_39E94FA093CC](/claim/clm_39E94FA093CC.md) - 2018-01-31 to 2019-01-31 | research_and_development | 755,500,000 United States dollar | superseded | [clm_6BE27C84D211](/claim/clm_6BE27C84D211.md) - 2018-01-31 to 2019-01-31 | net_income | -566,900,000 United States dollar | superseded | [clm_77B6C8A9C724](/claim/clm_77B6C8A9C724.md) - 2018-01-31 to 2019-01-31 | revenue | 2,056,600,000 United States dollar | superseded | [clm_AE85D9A9A887](/claim/clm_AE85D9A9A887.md) - 2018-01-31 to 2018-04-30 | total_assets | 4,113,600,000 United States dollar | superseded | [clm_B0874BF8D7F3](/claim/clm_B0874BF8D7F3.md) - 2018-01-31 to 2018-04-30 | cash_and_equivalents | 1,078,000,000 United States dollar | superseded | [clm_BFC4D3A6A9BB](/claim/clm_BFC4D3A6A9BB.md) - 2018-01-31 to 2019-01-31 | operating_income | -509,100,000 United States dollar | superseded | [clm_E776C2C40C17](/claim/clm_E776C2C40C17.md) - 2018-03-12 to 2018-06-04 | shares_outstanding | 218,327,862 shares | superseded | [clm_1D27120C03B3](/claim/clm_1D27120C03B3.md) - 2018-04-30 to 2018-07-31 | quarterly_revenue | 559,900,000 United States dollar | superseded | [clm_0C2575F93DA2](/claim/clm_0C2575F93DA2.md) - 2018-04-30 to 2018-07-31 | cash_and_equivalents | 1,093,000,000 United States dollar | superseded | [clm_70EFA7D88BEC](/claim/clm_70EFA7D88BEC.md) - 2018-04-30 to 2018-07-31 | total_assets | 3,911,400,000 United States dollar | superseded | [clm_81F50FD36D1D](/claim/clm_81F50FD36D1D.md) - 2018-04-30 to 2018-07-31 | quarterly_research_and_development | 172,800,000 United States dollar | superseded | [clm_A05164278F28](/claim/clm_A05164278F28.md) - 2018-04-30 to 2018-07-31 | quarterly_operating_income | -55,300,000 United States dollar | superseded | [clm_B70D1EF1F628](/claim/clm_B70D1EF1F628.md) - 2018-04-30 to 2018-07-31 | total_equity | -128,600,000 United States dollar | superseded | [clm_BDD63A5FE50B](/claim/clm_BDD63A5FE50B.md) - 2018-04-30 to 2018-07-31 | quarterly_net_income | -82,400,000 United States dollar | superseded | [clm_C2FAB5D54ECC](/claim/clm_C2FAB5D54ECC.md) - 2018-06-04 to 2018-08-24 | shares_outstanding | 219,145,087 shares | superseded | [clm_F1A5985FCEC6](/claim/clm_F1A5985FCEC6.md) - 2018-07-31 to 2018-10-31 | quarterly_revenue | 611,700,000 United States dollar | superseded | [clm_40D98E13CCB8](/claim/clm_40D98E13CCB8.md) - 2018-07-31 to 2018-10-31 | total_equity | -241,600,000 United States dollar | superseded | [clm_474581438E74](/claim/clm_474581438E74.md) - 2018-07-31 to 2018-10-31 | total_assets | 3,833,000,000 United States dollar | superseded | [clm_7F95DD54BC56](/claim/clm_7F95DD54BC56.md) - 2018-07-31 to 2018-10-31 | quarterly_operating_income | -24,700,000 United States dollar | superseded | [clm_979B1C6E24C4](/claim/clm_979B1C6E24C4.md) - 2018-07-31 to 2018-10-31 | quarterly_net_income | -39,400,000 United States dollar | superseded | [clm_A1195D6839C5](/claim/clm_A1195D6839C5.md) - 2018-07-31 to 2018-10-31 | quarterly_research_and_development | 180,800,000 United States dollar | superseded | [clm_DF8A44A99C27](/claim/clm_DF8A44A99C27.md) - 2018-07-31 to 2018-10-31 | cash_and_equivalents | 895,400,000 United States dollar | superseded | [clm_F9ABCE0FFE96](/claim/clm_F9ABCE0FFE96.md) - 2018-08-24 to 2018-11-30 | shares_outstanding | 218,616,633 shares | superseded | [clm_252EBDAF65D3](/claim/clm_252EBDAF65D3.md) - 2018-10-31 to 2019-04-30 | quarterly_net_income | -23,700,000 United States dollar | superseded | [clm_1DC76B454A78](/claim/clm_1DC76B454A78.md) - 2018-10-31 to 2019-04-30 | quarterly_operating_income | 14,700,000 United States dollar | superseded | [clm_21651F68071F](/claim/clm_21651F68071F.md) - 2018-10-31 to 2019-01-31 | total_equity | -338,300,000 United States dollar | superseded | [clm_48A710485592](/claim/clm_48A710485592.md) - 2018-10-31 to 2019-04-30 | quarterly_revenue | 660,900,000 United States dollar | superseded | [clm_490ABB01AF0D](/claim/clm_490ABB01AF0D.md) - 2018-10-31 to 2019-04-30 | quarterly_research_and_development | 181,000,000 United States dollar | superseded | [clm_8C5711D26C78](/claim/clm_8C5711D26C78.md) - 2018-10-31 to 2019-01-31 | total_assets | 3,774,400,000 United States dollar | superseded | [clm_97EC6DBA585D](/claim/clm_97EC6DBA585D.md) - 2018-10-31 to 2019-01-31 | cash_and_equivalents | 875,700,000 United States dollar | superseded | [clm_9D14191B029B](/claim/clm_9D14191B029B.md) - 2018-11-30 to 2019-03-15 | shares_outstanding | 219,008,836 shares | superseded | [clm_674C7266A666](/claim/clm_674C7266A666.md) ## 2019 - 2019-01-31 to 2019-04-30 | cash_and_equivalents | 886,000,000 United States dollar | superseded | [clm_02B31CB12558](/claim/clm_02B31CB12558.md) - 2019-01-31 to 2020-01-31 | net_income | -80,800,000 United States dollar | superseded | [clm_09B9A26140F3](/claim/clm_09B9A26140F3.md) - 2019-01-31 to 2020-01-31 | revenue | 2,569,800,000 United States dollar | superseded | [clm_5474EB069E21](/claim/clm_5474EB069E21.md) - 2019-01-31 to 2019-02-01 | total_assets | 4,729,200,000 United States dollar | superseded | [clm_A9113C4A5F40](/claim/clm_A9113C4A5F40.md) - 2019-01-31 to 2019-04-30 | total_equity | -210,900,000 United States dollar | superseded | [clm_CEDA4EF08B2C](/claim/clm_CEDA4EF08B2C.md) - 2019-01-31 to 2020-01-31 | research_and_development | 725,000,000 United States dollar | superseded | [clm_E373B595A38C](/claim/clm_E373B595A38C.md) - 2019-01-31 to 2020-01-31 | operating_income | -25,000,000 United States dollar | superseded | [clm_E98522BBAA3A](/claim/clm_E98522BBAA3A.md) - 2019-02-01 to 2019-04-30 | total_assets | 5,006,700,000 United States dollar | superseded | [clm_41CDD6AD36A3](/claim/clm_41CDD6AD36A3.md) - 2019-03-15 to 2019-05-29 | shares_outstanding | 219,535,216 shares | superseded | [clm_5B1DDBECC133](/claim/clm_5B1DDBECC133.md) - 2019-04-30 to 2019-07-31 | quarterly_revenue | 735,500,000 United States dollar | superseded | [clm_065DCDE625F7](/claim/clm_065DCDE625F7.md) - 2019-04-30 to 2019-07-31 | total_assets | 4,808,500,000 United States dollar | superseded | [clm_2E0BC857923A](/claim/clm_2E0BC857923A.md) - 2019-04-30 to 2019-07-31 | quarterly_net_income | -24,200,000 United States dollar | superseded | [clm_7E3E39C89F6F](/claim/clm_7E3E39C89F6F.md) - 2019-04-30 to 2019-07-31 | quarterly_research_and_development | 205,600,000 United States dollar | superseded | [clm_8359A35ACA01](/claim/clm_8359A35ACA01.md) - 2019-04-30 to 2019-07-31 | total_equity | -245,300,000 United States dollar | superseded | [clm_ABC2F1AB6DB3](/claim/clm_ABC2F1AB6DB3.md) - 2019-04-30 to 2019-07-31 | quarterly_operating_income | 24,800,000 United States dollar | superseded | [clm_B4D874457162](/claim/clm_B4D874457162.md) - 2019-04-30 to 2019-07-31 | cash_and_equivalents | 883,200,000 United States dollar | superseded | [clm_E08AF3C1B808](/claim/clm_E08AF3C1B808.md) - 2019-05-29 to 2019-07-31 | shares_outstanding | 219,619,580 shares | superseded | [clm_DC5834979AAA](/claim/clm_DC5834979AAA.md) - 2019-07-31 to 2019-10-31 | quarterly_net_income | 40,200,000 United States dollar | superseded | [clm_2AB3FC3B2F86](/claim/clm_2AB3FC3B2F86.md) - 2019-07-31 to 2019-10-31 | cash_and_equivalents | 923,900,000 United States dollar | superseded | [clm_5F54CB5FAD49](/claim/clm_5F54CB5FAD49.md) - 2019-07-31 to 2019-10-31 | total_assets | 4,872,700,000 United States dollar | superseded | [clm_7B1A05AB4C11](/claim/clm_7B1A05AB4C11.md) - 2019-07-31 to 2019-08-29 | shares_outstanding | 219,800,000 shares | superseded | [clm_8D416EC59879](/claim/clm_8D416EC59879.md) - 2019-07-31 to 2019-10-31 | quarterly_operating_income | 73,800,000 United States dollar | superseded | [clm_9161CF5EB045](/claim/clm_9161CF5EB045.md) - 2019-07-31 to 2019-10-31 | total_equity | -194,300,000 United States dollar | superseded | [clm_A70868835E05](/claim/clm_A70868835E05.md) - 2019-07-31 to 2019-10-31 | quarterly_revenue | 796,800,000 United States dollar | superseded | [clm_D90CE267D7AF](/claim/clm_D90CE267D7AF.md) - 2019-07-31 to 2019-10-31 | quarterly_research_and_development | 215,400,000 United States dollar | superseded | [clm_EA906D4CB1EA](/claim/clm_EA906D4CB1EA.md) - 2019-08-29 to 2019-11-30 | shares_outstanding | 219,587,608 shares | superseded | [clm_6EEEF01DF88D](/claim/clm_6EEEF01DF88D.md) - 2019-10-31 to 2020-01-31 | total_assets | 5,036,600,000 United States dollar | superseded | [clm_0EB32B3B2DFC](/claim/clm_0EB32B3B2DFC.md) - 2019-10-31 to 2020-01-31 | cash_and_equivalents | 956,200,000 United States dollar | superseded | [clm_16CE198CC488](/claim/clm_16CE198CC488.md) - 2019-10-31 to 2020-01-31 | total_equity | -171,500,000 United States dollar | superseded | [clm_1A0E87E812F4](/claim/clm_1A0E87E812F4.md) - 2019-10-31 to 2020-04-30 | quarterly_research_and_development | 213,000,000 United States dollar | superseded | [clm_714149A80D2B](/claim/clm_714149A80D2B.md) - 2019-10-31 to 2020-04-30 | quarterly_operating_income | 110,600,000 United States dollar | superseded | [clm_806B287C47C4](/claim/clm_806B287C47C4.md) - 2019-10-31 to 2020-04-30 | quarterly_revenue | 842,700,000 United States dollar | superseded | [clm_F1734BDD2671](/claim/clm_F1734BDD2671.md) - 2019-10-31 to 2020-04-30 | quarterly_net_income | 66,700,000 United States dollar | superseded | [clm_FDA69F4B6FC5](/claim/clm_FDA69F4B6FC5.md) - 2019-11-30 to 2020-03-13 | shares_outstanding | 220,033,002 shares | superseded | [clm_BAD13254B535](/claim/clm_BAD13254B535.md) ## 2020 - 2020-01-31 to 2021-01-31 | net_income | 214,500,000 United States dollar | superseded | [clm_01A6F622F36B](/claim/clm_01A6F622F36B.md) - 2020-01-31 to 2020-04-30 | total_assets | 6,179,300,000 United States dollar | superseded | [clm_0A97190F3A8D](/claim/clm_0A97190F3A8D.md) - 2020-01-31 to 2020-04-30 | cash_and_equivalents | 1,774,700,000 United States dollar | superseded | [clm_3F2D5731581F](/claim/clm_3F2D5731581F.md) - 2020-01-31 to 2021-01-31 | research_and_development | 851,100,000 United States dollar | superseded | [clm_41E9C3933F3D](/claim/clm_41E9C3933F3D.md) - 2020-01-31 to 2021-01-31 | revenue | 3,274,300,000 United States dollar | superseded | [clm_6FA259939EC2](/claim/clm_6FA259939EC2.md) - 2020-01-31 to 2021-01-31 | operating_income | 343,000,000 United States dollar | superseded | [clm_91366B7D5108](/claim/clm_91366B7D5108.md) - 2020-01-31 to 2020-04-30 | total_equity | -139,100,000 United States dollar | superseded | [clm_C3E5C904D4CC](/claim/clm_C3E5C904D4CC.md) - 2020-03-13 to 2020-05-29 | shares_outstanding | 219,521,425 shares | superseded | [clm_149802B90E1B](/claim/clm_149802B90E1B.md) - 2020-04-30 to 2020-07-31 | total_assets | 5,543,900,000 United States dollar | superseded | [clm_3E66DFFC7FA0](/claim/clm_3E66DFFC7FA0.md) - 2020-04-30 to 2020-07-31 | quarterly_revenue | 885,700,000 United States dollar | superseded | [clm_527B826EF588](/claim/clm_527B826EF588.md) - 2020-04-30 to 2020-07-31 | total_equity | -139,100,000 United States dollar | superseded | [clm_734F230CCE19](/claim/clm_734F230CCE19.md) - 2020-04-30 to 2020-07-31 | quarterly_operating_income | 130,600,000 United States dollar | superseded | [clm_827FAA702059](/claim/clm_827FAA702059.md) - 2020-04-30 to 2020-07-31 | quarterly_net_income | 66,500,000 United States dollar | superseded | [clm_8AB358A4A245](/claim/clm_8AB358A4A245.md) - 2020-04-30 to 2020-07-31 | quarterly_research_and_development | 217,400,000 United States dollar | superseded | [clm_8C89FC7E897C](/claim/clm_8C89FC7E897C.md) - 2020-04-30 to 2020-07-31 | cash_and_equivalents | 1,389,700,000 United States dollar | superseded | [clm_F902796DF36E](/claim/clm_F902796DF36E.md) - 2020-05-29 to 2020-08-28 | shares_outstanding | 219,196,718 shares | superseded | [clm_166BE61A571D](/claim/clm_166BE61A571D.md) - 2020-07-31 to 2020-10-31 | total_equity | 67,300,000 United States dollar | superseded | [clm_4F991DA1C295](/claim/clm_4F991DA1C295.md) - 2020-07-31 to 2020-10-31 | quarterly_revenue | 913,100,000 United States dollar | superseded | [clm_92E99A756B32](/claim/clm_92E99A756B32.md) - 2020-07-31 to 2020-10-31 | quarterly_operating_income | 146,100,000 United States dollar | superseded | [clm_9FEFD977DDB9](/claim/clm_9FEFD977DDB9.md) - 2020-07-31 to 2020-10-31 | cash_and_equivalents | 1,439,800,000 United States dollar | superseded | [clm_AD20047D79CD](/claim/clm_AD20047D79CD.md) - 2020-07-31 to 2020-10-31 | quarterly_research_and_development | 232,500,000 United States dollar | superseded | [clm_B6987783CDC2](/claim/clm_B6987783CDC2.md) - 2020-07-31 to 2020-10-31 | total_assets | 5,747,300,000 United States dollar | superseded | [clm_D67191D7A5A8](/claim/clm_D67191D7A5A8.md) - 2020-07-31 to 2020-10-31 | quarterly_net_income | 98,200,000 United States dollar | superseded | [clm_FCEBC7C9856C](/claim/clm_FCEBC7C9856C.md) - 2020-08-28 to 2020-11-30 | shares_outstanding | 219,279,183 shares | superseded | [clm_001F67FB39C0](/claim/clm_001F67FB39C0.md) - 2020-10-31 to 2021-01-31 | total_assets | 5,944,500,000 United States dollar | superseded | [clm_1FCD375BAB9E](/claim/clm_1FCD375BAB9E.md) - 2020-10-31 to 2021-01-31 | total_equity | 69,300,000 United States dollar | superseded | [clm_231587488D3E](/claim/clm_231587488D3E.md) - 2020-10-31 to 2021-04-30 | quarterly_net_income | 132,200,000 United States dollar | superseded | [clm_6318015F261B](/claim/clm_6318015F261B.md) - 2020-10-31 to 2021-04-30 | quarterly_operating_income | 168,000,000 United States dollar | superseded | [clm_99EC2C2DAEDD](/claim/clm_99EC2C2DAEDD.md) - 2020-10-31 to 2021-01-31 | cash_and_equivalents | 1,537,000,000 United States dollar | superseded | [clm_C7E1F82E7B0D](/claim/clm_C7E1F82E7B0D.md) - 2020-10-31 to 2021-04-30 | quarterly_research_and_development | 233,000,000 United States dollar | superseded | [clm_E268D816BEB3](/claim/clm_E268D816BEB3.md) - 2020-10-31 to 2021-04-30 | quarterly_revenue | 952,400,000 United States dollar | superseded | [clm_F5DB9CBDA7F3](/claim/clm_F5DB9CBDA7F3.md) - 2020-11-30 to 2021-03-12 | shares_outstanding | 219,889,403 shares | superseded | [clm_0B0F29821BBD](/claim/clm_0B0F29821BBD.md) ## 2021 - 2021-01-31 to 2022-01-31 | revenue | 3,790,400,000 United States dollar | superseded | [clm_13BB897272B6](/claim/clm_13BB897272B6.md) - 2021-01-31 to 2022-01-31 | research_and_development | 932,500,000 United States dollar | superseded | [clm_1D4F68AE8146](/claim/clm_1D4F68AE8146.md) - 2021-01-31 to 2022-01-31 | operating_income | 629,100,000 United States dollar | superseded | [clm_5DA5BE45CBA2](/claim/clm_5DA5BE45CBA2.md) - 2021-01-31 to 2021-04-30 | total_assets | 7,279,800,000 United States dollar | superseded | [clm_7B489F1150E5](/claim/clm_7B489F1150E5.md) - 2021-01-31 to 2021-04-30 | cash_and_equivalents | 1,772,200,000 United States dollar | superseded | [clm_89DF71DAA3C1](/claim/clm_89DF71DAA3C1.md) - 2021-01-31 to 2022-01-31 | net_income | 1,208,200,000 United States dollar | superseded | [clm_C9EE826458EA](/claim/clm_C9EE826458EA.md) - 2021-01-31 to 2021-04-30 | total_equity | 965,500,000 United States dollar | superseded | [clm_FC742458C4E9](/claim/clm_FC742458C4E9.md) - 2021-03-12 to 2021-05-31 | shares_outstanding | 219,592,294 shares | superseded | [clm_6786271C9DD4](/claim/clm_6786271C9DD4.md) - 2021-04-30 to 2021-07-31 | quarterly_revenue | 989,300,000 United States dollar | superseded | [clm_38FBF5D4FC6B](/claim/clm_38FBF5D4FC6B.md) - 2021-04-30 to 2021-07-31 | total_equity | 1,128,400,000 United States dollar | superseded | [clm_5052C495CEF5](/claim/clm_5052C495CEF5.md) - 2021-04-30 to 2021-07-31 | quarterly_net_income | 155,600,000 United States dollar | superseded | [clm_7A8DED8C3874](/claim/clm_7A8DED8C3874.md) - 2021-04-30 to 2021-07-31 | quarterly_operating_income | 133,800,000 United States dollar | superseded | [clm_8EE0D798CA6D](/claim/clm_8EE0D798CA6D.md) - 2021-04-30 to 2021-07-31 | cash_and_equivalents | 923,200,000 United States dollar | superseded | [clm_A911B528AF5E](/claim/clm_A911B528AF5E.md) - 2021-04-30 to 2021-07-31 | total_assets | 7,298,300,000 United States dollar | superseded | [clm_C506010116BE](/claim/clm_C506010116BE.md) - 2021-04-30 to 2021-07-31 | quarterly_research_and_development | 265,500,000 United States dollar | superseded | [clm_CE0EB49E7920](/claim/clm_CE0EB49E7920.md) - 2021-05-31 to 2021-08-27 | shares_outstanding | 220,013,315 shares | superseded | [clm_A496A0EAA14F](/claim/clm_A496A0EAA14F.md) - 2021-07-31 to 2021-10-31 | total_equity | 1,327,800,000 United States dollar | superseded | [clm_36B6631B4045](/claim/clm_36B6631B4045.md) - 2021-07-31 to 2021-10-31 | quarterly_research_and_development | 276,900,000 United States dollar | superseded | [clm_3B54514D46F0](/claim/clm_3B54514D46F0.md) - 2021-07-31 to 2021-10-31 | quarterly_net_income | 115,600,000 United States dollar | superseded | [clm_4768805A5C98](/claim/clm_4768805A5C98.md) - 2021-07-31 to 2021-10-31 | total_assets | 7,420,600,000 United States dollar | superseded | [clm_D44EBD220AC4](/claim/clm_D44EBD220AC4.md) - 2021-07-31 to 2021-10-31 | cash_and_equivalents | 923,500,000 United States dollar | superseded | [clm_DDDE64E664AC](/claim/clm_DDDE64E664AC.md) - 2021-07-31 to 2021-10-31 | quarterly_operating_income | 148,100,000 United States dollar | superseded | [clm_F90D0842D4BA](/claim/clm_F90D0842D4BA.md) - 2021-07-31 to 2021-10-31 | quarterly_revenue | 1,059,700,000 United States dollar | superseded | [clm_FC865473889B](/claim/clm_FC865473889B.md) - 2021-08-27 to 2021-11-30 | shares_outstanding | 219,850,441 shares | superseded | [clm_2D461F9F1EED](/claim/clm_2D461F9F1EED.md) - 2021-10-31 to 2022-01-31 | total_equity | 1,279,900,000 United States dollar | superseded | [clm_05D1C36D08AA](/claim/clm_05D1C36D08AA.md) - 2021-10-31 to 2022-01-31 | cash_and_equivalents | 1,748,900,000 United States dollar | superseded | [clm_4830D7FB3021](/claim/clm_4830D7FB3021.md) - 2021-10-31 to 2022-04-30 | quarterly_research_and_development | 282,100,000 United States dollar | superseded | [clm_4E01C3971594](/claim/clm_4E01C3971594.md) - 2021-10-31 to 2022-04-30 | quarterly_operating_income | 193,300,000 United States dollar | superseded | [clm_8297A25BFD1F](/claim/clm_8297A25BFD1F.md) - 2021-10-31 to 2022-04-30 | quarterly_revenue | 1,125,800,000 United States dollar | superseded | [clm_8FE0C7803198](/claim/clm_8FE0C7803198.md) - 2021-10-31 to 2022-01-31 | total_assets | 8,531,000,000 United States dollar | superseded | [clm_A11E5916A23A](/claim/clm_A11E5916A23A.md) - 2021-10-31 to 2022-04-30 | quarterly_net_income | 136,700,000 United States dollar | superseded | [clm_CA3EB0702121](/claim/clm_CA3EB0702121.md) - 2021-11-30 to 2022-03-10 | shares_outstanding | 219,973,417 shares | superseded | [clm_49886D782BE7](/claim/clm_49886D782BE7.md) ## 2022 - 2022-01-31 to 2022-04-30 | cash_and_equivalents | 1,528,400,000 United States dollar | superseded | [clm_1D27ECD84496](/claim/clm_1D27ECD84496.md) - 2022-01-31 to 2023-01-31 | net_income | 497,000,000 United States dollar | superseded | [clm_3DEE958F6C88](/claim/clm_3DEE958F6C88.md) - 2022-01-31 to 2023-01-31 | research_and_development | 1,114,800,000 United States dollar | superseded | [clm_4ACFA35A4842](/claim/clm_4ACFA35A4842.md) - 2022-01-31 to 2022-04-30 | total_assets | 8,606,800,000 United States dollar | superseded | [clm_8D3BF5AF6FEC](/claim/clm_8D3BF5AF6FEC.md) - 2022-01-31 to 2022-04-30 | total_equity | 849,100,000 United States dollar | superseded | [clm_9896F06806FF](/claim/clm_9896F06806FF.md) - 2022-01-31 to 2023-01-31 | operating_income | 617,600,000 United States dollar | superseded | [clm_B48A035B755F](/claim/clm_B48A035B755F.md) - 2022-01-31 to 2023-01-31 | revenue | 4,386,400,000 United States dollar | superseded | [clm_C7D4721BCB43](/claim/clm_C7D4721BCB43.md) - 2022-03-10 to 2022-05-27 | shares_outstanding | 217,307,974 shares | superseded | [clm_50AA9A6C7343](/claim/clm_50AA9A6C7343.md) - 2022-04-30 to 2022-07-31 | cash_and_equivalents | 1,518,000,000 United States dollar | superseded | [clm_0FB1FEB633A3](/claim/clm_0FB1FEB633A3.md) - 2022-04-30 to 2022-07-31 | total_assets | 8,261,000,000 United States dollar | superseded | [clm_1226476F51F3](/claim/clm_1226476F51F3.md) - 2022-04-30 to 2022-07-31 | quarterly_operating_income | 214,000,000 United States dollar | superseded | [clm_6DA900FAC745](/claim/clm_6DA900FAC745.md) - 2022-04-30 to 2022-07-31 | quarterly_research_and_development | 289,000,000 United States dollar | superseded | [clm_977F3FB7C9F9](/claim/clm_977F3FB7C9F9.md) - 2022-04-30 to 2022-07-31 | quarterly_net_income | 146,000,000 United States dollar | superseded | [clm_AF779B643F0E](/claim/clm_AF779B643F0E.md) - 2022-04-30 to 2022-07-31 | total_equity | 681,000,000 United States dollar | superseded | [clm_B7FD95AB23F7](/claim/clm_B7FD95AB23F7.md) - 2022-04-30 to 2022-07-31 | quarterly_revenue | 1,170,000,000 United States dollar | superseded | [clm_E2F55DAA9662](/claim/clm_E2F55DAA9662.md) - 2022-05-27 to 2022-08-25 | shares_outstanding | 217,272,205 shares | superseded | [clm_08AAA421943F](/claim/clm_08AAA421943F.md) - 2022-07-31 to 2022-10-31 | total_equity | 740,000,000 United States dollar | superseded | [clm_4A26E4E14376](/claim/clm_4A26E4E14376.md) - 2022-07-31 to 2022-10-31 | quarterly_net_income | 186,000,000 United States dollar | superseded | [clm_5EB9EE3698E0](/claim/clm_5EB9EE3698E0.md) - 2022-07-31 to 2022-10-31 | quarterly_revenue | 1,237,000,000 United States dollar | superseded | [clm_6B3AF6AE7C26](/claim/clm_6B3AF6AE7C26.md) - 2022-07-31 to 2022-10-31 | quarterly_operating_income | 242,000,000 United States dollar | superseded | [clm_7B2F4B6DBEFB](/claim/clm_7B2F4B6DBEFB.md) - 2022-07-31 to 2022-10-31 | cash_and_equivalents | 1,440,000,000 United States dollar | superseded | [clm_895A15826400](/claim/clm_895A15826400.md) - 2022-07-31 to 2022-10-31 | total_assets | 8,227,000,000 United States dollar | superseded | [clm_8CDDA55017FB](/claim/clm_8CDDA55017FB.md) - 2022-07-31 to 2022-10-31 | quarterly_research_and_development | 306,000,000 United States dollar | superseded | [clm_EAF53EAEF6F0](/claim/clm_EAF53EAEF6F0.md) - 2022-08-25 to 2022-11-30 | shares_outstanding | 215,859,048 shares | superseded | [clm_B99169A87B7B](/claim/clm_B99169A87B7B.md) - 2022-10-31 to 2023-01-31 | total_assets | 8,635,000,000 United States dollar | superseded | [clm_05209754E3D8](/claim/clm_05209754E3D8.md) - 2022-10-31 to 2023-01-31 | cash_and_equivalents | 1,665,000,000 United States dollar | superseded | [clm_0B1C0B2896E9](/claim/clm_0B1C0B2896E9.md) - 2022-10-31 to 2023-04-30 | quarterly_research_and_development | 311,000,000 United States dollar | superseded | [clm_1F37B04B24ED](/claim/clm_1F37B04B24ED.md) - 2022-10-31 to 2023-04-30 | quarterly_revenue | 1,280,000,000 United States dollar | superseded | [clm_3780F5B33BD2](/claim/clm_3780F5B33BD2.md) - 2022-10-31 to 2023-01-31 | total_equity | 906,000,000 United States dollar | superseded | [clm_79EEB5D687DC](/claim/clm_79EEB5D687DC.md) - 2022-10-31 to 2023-04-30 | quarterly_operating_income | 256,000,000 United States dollar | superseded | [clm_D63B0EAC9496](/claim/clm_D63B0EAC9496.md) - 2022-10-31 to 2023-04-30 | quarterly_net_income | 198,000,000 United States dollar | superseded | [clm_E5A0247FD6B6](/claim/clm_E5A0247FD6B6.md) - 2022-11-30 to 2023-03-07 | shares_outstanding | 215,767,494 shares | superseded | [clm_6DB075110039](/claim/clm_6DB075110039.md) ## 2023 - 2023-01-31 to 2024-01-31 | research_and_development | 1,219,000,000 United States dollar | superseded | [clm_0A4FC1B45037](/claim/clm_0A4FC1B45037.md) - 2023-01-31 to 2023-04-30 | total_assets | 9,438,000,000 United States dollar | superseded | [clm_546503385C54](/claim/clm_546503385C54.md) - 2023-01-31 to 2024-01-31 | revenue | 5,005,000,000 United States dollar | superseded | [clm_588AB8ADF122](/claim/clm_588AB8ADF122.md) - 2023-01-31 to 2023-04-30 | cash_and_equivalents | 1,947,000,000 United States dollar | superseded | [clm_5DE57EA341C4](/claim/clm_5DE57EA341C4.md) - 2023-01-31 to 2024-01-31 | net_income | 823,000,000 United States dollar | superseded | [clm_7E4B088637DF](/claim/clm_7E4B088637DF.md) - 2023-01-31 to 2023-04-30 | total_equity | 1,145,000,000 United States dollar | superseded | [clm_974801232591](/claim/clm_974801232591.md) - 2023-01-31 to 2024-01-31 | operating_income | 989,000,000 United States dollar | superseded | [clm_C129589687FE](/claim/clm_C129589687FE.md) - 2023-03-07 to 2023-05-24 | shares_outstanding | 214,782,702 shares | superseded | [clm_CA526604697B](/claim/clm_CA526604697B.md) - 2023-04-30 to 2023-07-31 | total_equity | 897,000,000 United States dollar | superseded | [clm_0A01BE93FF83](/claim/clm_0A01BE93FF83.md) - 2023-04-30 to 2023-07-31 | quarterly_net_income | 161,000,000 United States dollar | superseded | [clm_370FD657A84D](/claim/clm_370FD657A84D.md) - 2023-04-30 to 2023-07-31 | total_assets | 9,069,000,000 United States dollar | superseded | [clm_4C8D3201F227](/claim/clm_4C8D3201F227.md) - 2023-04-30 to 2023-07-31 | quarterly_research_and_development | 327,000,000 United States dollar | superseded | [clm_5FEC79D07079](/claim/clm_5FEC79D07079.md) - 2023-04-30 to 2023-07-31 | quarterly_revenue | 1,269,000,000 United States dollar | superseded | [clm_91940A7EAEDC](/claim/clm_91940A7EAEDC.md) - 2023-04-30 to 2023-07-31 | cash_and_equivalents | 1,909,000,000 United States dollar | superseded | [clm_DD6FE8885E11](/claim/clm_DD6FE8885E11.md) - 2023-04-30 to 2023-07-31 | quarterly_operating_income | 217,000,000 United States dollar | superseded | [clm_E229950B2FB3](/claim/clm_E229950B2FB3.md) - 2023-05-24 to 2023-08-23 | shares_outstanding | 213,726,419 shares | superseded | [clm_6899F02C659B](/claim/clm_6899F02C659B.md) - 2023-07-31 to 2023-10-31 | cash_and_equivalents | 1,714,000,000 United States dollar | superseded | [clm_00387BC6DF95](/claim/clm_00387BC6DF95.md) - 2023-07-31 to 2023-10-31 | quarterly_research_and_development | 355,000,000 United States dollar | superseded | [clm_48E264D40C9F](/claim/clm_48E264D40C9F.md) - 2023-07-31 to 2023-10-31 | quarterly_revenue | 1,345,000,000 United States dollar | superseded | [clm_5F391F7655F9](/claim/clm_5F391F7655F9.md) - 2023-07-31 to 2023-10-31 | total_equity | 1,206,000,000 United States dollar | superseded | [clm_80A2F3F2EF5A](/claim/clm_80A2F3F2EF5A.md) - 2023-07-31 to 2023-10-31 | quarterly_operating_income | 262,000,000 United States dollar | superseded | [clm_9D671990D2EA](/claim/clm_9D671990D2EA.md) - 2023-07-31 to 2023-10-31 | quarterly_net_income | 222,000,000 United States dollar | superseded | [clm_D635EF194D9E](/claim/clm_D635EF194D9E.md) - 2023-07-31 to 2023-10-31 | total_assets | 9,107,000,000 United States dollar | superseded | [clm_DA14AF3F2F90](/claim/clm_DA14AF3F2F90.md) - 2023-08-23 to 2023-11-27 | shares_outstanding | 213,763,632 shares | superseded | [clm_92F512568F82](/claim/clm_92F512568F82.md) - 2023-10-31 to 2024-04-30 | quarterly_net_income | 241,000,000 United States dollar | superseded | [clm_0A7BA74E1F12](/claim/clm_0A7BA74E1F12.md) - 2023-10-31 to 2024-01-31 | total_assets | 9,226,000,000 United States dollar | superseded | [clm_22BF7C5433A9](/claim/clm_22BF7C5433A9.md) - 2023-10-31 to 2024-01-31 | total_equity | 1,482,000,000 United States dollar | superseded | [clm_6E57DBB90A8D](/claim/clm_6E57DBB90A8D.md) - 2023-10-31 to 2024-04-30 | quarterly_research_and_development | 339,000,000 United States dollar | superseded | [clm_739662152513](/claim/clm_739662152513.md) - 2023-10-31 to 2024-01-31 | cash_and_equivalents | 1,526,000,000 United States dollar | superseded | [clm_7A3F70342DEA](/claim/clm_7A3F70342DEA.md) - 2023-10-31 to 2024-04-30 | quarterly_operating_income | 334,000,000 United States dollar | superseded | [clm_A7EF849D2382](/claim/clm_A7EF849D2382.md) - 2023-10-31 to 2024-04-30 | quarterly_revenue | 1,414,000,000 United States dollar | superseded | [clm_FD3B9DA1D729](/claim/clm_FD3B9DA1D729.md) - 2023-11-27 to 2024-03-31 | shares_outstanding | 213,915,325 shares | superseded | [clm_A6D72F33E942](/claim/clm_A6D72F33E942.md) ## 2024 - 2024-01-31 to 2025-01-31 | operating_income | 1,128,000,000 United States dollar | superseded | [clm_A3D0C9327E54](/claim/clm_A3D0C9327E54.md) - 2024-01-31 to 2025-01-31 | net_income | 906,000,000 United States dollar | superseded | [clm_A4E45F91575A](/claim/clm_A4E45F91575A.md) - 2024-01-31 to 2025-01-31 | revenue | 5,497,000,000 United States dollar | superseded | [clm_ABF762C254A9](/claim/clm_ABF762C254A9.md) - 2024-01-31 to 2024-04-30 | total_equity | 1,855,000,000 United States dollar | superseded | [clm_BE56F8D3632A](/claim/clm_BE56F8D3632A.md) - 2024-01-31 to 2024-04-30 | cash_and_equivalents | 1,892,000,000 United States dollar | superseded | [clm_D541AA499902](/claim/clm_D541AA499902.md) - 2024-01-31 to 2024-04-30 | total_assets | 9,912,000,000 United States dollar | superseded | [clm_E0255D19B7A2](/claim/clm_E0255D19B7A2.md) - 2024-01-31 to 2025-01-31 | research_and_development | 1,373,000,000 United States dollar | superseded | [clm_F6D16A0E2B40](/claim/clm_F6D16A0E2B40.md) - 2024-03-31 to 2024-05-24 | shares_outstanding | 215,446,979 shares | superseded | [clm_87B4F3F71485](/claim/clm_87B4F3F71485.md) - 2024-04-30 to 2024-07-31 | cash_and_equivalents | 1,681,000,000 United States dollar | superseded | [clm_019ED3952787](/claim/clm_019ED3952787.md) - 2024-04-30 to 2024-07-31 | total_assets | 9,830,000,000 United States dollar | superseded | [clm_283E38A7B44C](/claim/clm_283E38A7B44C.md) - 2024-04-30 to 2024-07-31 | total_equity | 2,161,000,000 United States dollar | superseded | [clm_6B6E4B1035F4](/claim/clm_6B6E4B1035F4.md) - 2024-04-30 to 2024-07-31 | quarterly_net_income | 252,000,000 United States dollar | superseded | [clm_74164D0A8A4D](/claim/clm_74164D0A8A4D.md) - 2024-04-30 to 2024-07-31 | quarterly_operating_income | 299,000,000 United States dollar | superseded | [clm_B1C4FF84577C](/claim/clm_B1C4FF84577C.md) - 2024-04-30 to 2024-07-31 | quarterly_revenue | 1,417,000,000 United States dollar | superseded | [clm_CFCD331676E5](/claim/clm_CFCD331676E5.md) - 2024-04-30 to 2024-07-31 | quarterly_research_and_development | 346,000,000 United States dollar | superseded | [clm_F3051754DBF4](/claim/clm_F3051754DBF4.md) - 2024-05-24 to 2024-08-23 | shares_outstanding | 216,000,000 shares | superseded | [clm_722C0E68C9F2](/claim/clm_722C0E68C9F2.md) - 2024-05-31 | cfo | Elizabeth Rafael | valid | [clm_01E63BEA33E7](/claim/clm_01E63BEA33E7.md) - 2024-07-31 to 2024-10-31 | total_assets | 9,960,000,000 United States dollar | superseded | [clm_4B3BAA8CFA95](/claim/clm_4B3BAA8CFA95.md) - 2024-07-31 to 2024-10-31 | quarterly_operating_income | 343,000,000 United States dollar | superseded | [clm_6DD6EECD4A28](/claim/clm_6DD6EECD4A28.md) - 2024-07-31 to 2024-10-31 | quarterly_research_and_development | 368,000,000 United States dollar | superseded | [clm_92950EE660A6](/claim/clm_92950EE660A6.md) - 2024-07-31 to 2024-10-31 | quarterly_revenue | 1,505,000,000 United States dollar | superseded | [clm_A473EBD1EA6D](/claim/clm_A473EBD1EA6D.md) - 2024-07-31 to 2024-10-31 | total_equity | 2,474,000,000 United States dollar | superseded | [clm_DF7BA2738D86](/claim/clm_DF7BA2738D86.md) - 2024-07-31 to 2024-10-31 | quarterly_net_income | 282,000,000 United States dollar | superseded | [clm_F2BA4B27D341](/claim/clm_F2BA4B27D341.md) - 2024-07-31 to 2024-10-31 | cash_and_equivalents | 1,513,000,000 United States dollar | superseded | [clm_FA6AC2D84076](/claim/clm_FA6AC2D84076.md) - 2024-08-23 to 2024-11-22 | shares_outstanding | 215,000,000 shares | superseded | [clm_E141034DF7BD](/claim/clm_E141034DF7BD.md) - 2024-10-31 to 2025-04-30 | quarterly_revenue | 1,570,000,000 United States dollar | superseded | [clm_2030786A5962](/claim/clm_2030786A5962.md) - 2024-10-31 to 2025-04-30 | quarterly_net_income | 275,000,000 United States dollar | superseded | [clm_2D52777BDA4A](/claim/clm_2D52777BDA4A.md) - 2024-10-31 to 2025-01-31 | total_assets | 10,133,000,000 United States dollar | superseded | [clm_4EA44CCD7B81](/claim/clm_4EA44CCD7B81.md) - 2024-10-31 to 2025-01-31 | total_equity | 2,616,000,000 United States dollar | superseded | [clm_5587542EDF87](/claim/clm_5587542EDF87.md) - 2024-10-31 to 2025-04-30 | quarterly_research_and_development | 378,000,000 United States dollar | superseded | [clm_6333978C6030](/claim/clm_6333978C6030.md) - 2024-10-31 to 2025-01-31 | cash_and_equivalents | 1,437,000,000 United States dollar | superseded | [clm_E0453F96B1C4](/claim/clm_E0453F96B1C4.md) - 2024-10-31 to 2025-04-30 | quarterly_operating_income | 346,000,000 United States dollar | superseded | [clm_E8EE5BA13AF3](/claim/clm_E8EE5BA13AF3.md) - 2024-11-22 to 2025-02-28 | shares_outstanding | 215,000,000 shares | superseded | [clm_0799194FE262](/claim/clm_0799194FE262.md) - 2024-12-18 | board_member | John T. Cahill | valid | [clm_4EF501C80BC5](/claim/clm_4EF501C80BC5.md) - 2024-12-18 | board_member | Ram Krishnan | valid | [clm_ABB8F8323BDB](/claim/clm_ABB8F8323BDB.md) ## 2025 - 2025-01-31 to 2026-01-31 | research_and_development | 1,485,000,000 United States dollar | superseded | [clm_2316A5F868DC](/claim/clm_2316A5F868DC.md) - 2025-01-31 to 2025-04-30 | cash_and_equivalents | 1,599,000,000 United States dollar | superseded | [clm_4A9BC0145E51](/claim/clm_4A9BC0145E51.md) - 2025-01-31 to 2025-04-30 | total_assets | 10,833,000,000 United States dollar | superseded | [clm_4EB0E0A11F8D](/claim/clm_4EB0E0A11F8D.md) - 2025-01-31 to 2026-01-31 | revenue | 6,131,000,000 United States dollar | superseded | [clm_933224029670](/claim/clm_933224029670.md) - 2025-01-31 to 2026-01-31 | net_income | 1,112,000,000 United States dollar | superseded | [clm_9DF9ED03438E](/claim/clm_9DF9ED03438E.md) - 2025-01-31 to 2025-04-30 | total_equity | 2,621,000,000 United States dollar | superseded | [clm_A265751DFE82](/claim/clm_A265751DFE82.md) - 2025-01-31 to 2026-01-31 | operating_income | 1,354,000,000 United States dollar | superseded | [clm_EA930D63902A](/claim/clm_EA930D63902A.md) - 2025-02-27 | restructuring | Worldwide restructuring plan cutting about 9% of workforce, reallocating to cloud and AI | valid | [clm_DFE040770C6F](/claim/clm_DFE040770C6F.md) - 2025-02-28 to 2025-05-22 | shares_outstanding | 213,000,000 shares | superseded | [clm_ABAB7EDA9812](/claim/clm_ABAB7EDA9812.md) - 2025-04-30 to 2025-07-31 | cash_and_equivalents | 1,816,000,000 United States dollar | superseded | [clm_588C63BDF567](/claim/clm_588C63BDF567.md) - 2025-04-30 to 2025-07-31 | quarterly_revenue | 1,633,000,000 United States dollar | superseded | [clm_6411962B52F7](/claim/clm_6411962B52F7.md) - 2025-04-30 to 2025-07-31 | quarterly_operating_income | 233,000,000 United States dollar | superseded | [clm_641827B831AF](/claim/clm_641827B831AF.md) - 2025-04-30 to 2025-07-31 | total_assets | 10,585,000,000 United States dollar | superseded | [clm_848585D65FEE](/claim/clm_848585D65FEE.md) - 2025-04-30 to 2025-07-31 | total_equity | 2,617,000,000 United States dollar | superseded | [clm_B3D14814735B](/claim/clm_B3D14814735B.md) - 2025-04-30 to 2025-07-31 | quarterly_research_and_development | 394,000,000 United States dollar | superseded | [clm_F419C4C923D2](/claim/clm_F419C4C923D2.md) - 2025-04-30 to 2025-07-31 | quarterly_net_income | 152,000,000 United States dollar | superseded | [clm_F610223D96DB](/claim/clm_F610223D96DB.md) - 2025-05-22 to 2025-08-26 | shares_outstanding | 214,000,000 shares | superseded | [clm_92BDB76856CC](/claim/clm_92BDB76856CC.md) - 2025-06-18 | board_member | A. Christine (Christie) Simons | valid | [clm_248C1A0E9822](/claim/clm_248C1A0E9822.md) - 2025-06-18 | board_member | Jeff Epstein | valid | [clm_B945F999AB2D](/claim/clm_B945F999AB2D.md) - 2025-07-31 to 2025-10-31 | cash_and_equivalents | 2,003,000,000 United States dollar | superseded | [clm_05A1AD93B9B5](/claim/clm_05A1AD93B9B5.md) - 2025-07-31 to 2025-10-31 | total_assets | 10,856,000,000 United States dollar | superseded | [clm_17B45E9D922C](/claim/clm_17B45E9D922C.md) - 2025-07-31 to 2025-10-31 | quarterly_operating_income | 444,000,000 United States dollar | superseded | [clm_241221A6192E](/claim/clm_241221A6192E.md) - 2025-07-31 to 2025-10-31 | quarterly_revenue | 1,763,000,000 United States dollar | superseded | [clm_40F57DD813FE](/claim/clm_40F57DD813FE.md) - 2025-07-31 to 2025-10-31 | quarterly_research_and_development | 413,000,000 United States dollar | superseded | [clm_463BE8A012AB](/claim/clm_463BE8A012AB.md) - 2025-07-31 to 2025-10-31 | total_equity | 2,715,000,000 United States dollar | superseded | [clm_743AF3E7C4AF](/claim/clm_743AF3E7C4AF.md) - 2025-07-31 to 2025-10-31 | quarterly_net_income | 313,000,000 United States dollar | superseded | [clm_A2A5D1EC8902](/claim/clm_A2A5D1EC8902.md) - 2025-08-26 to 2025-11-20 | shares_outstanding | 213,000,000 shares | superseded | [clm_0354E0E64727](/claim/clm_0354E0E64727.md) - 2025-10-31 to 2026-04-30 | quarterly_operating_income | 470,000,000 United States dollar | superseded | [clm_0B09A4894B07](/claim/clm_0B09A4894B07.md) - 2025-10-31 to 2026-04-30 | quarterly_revenue | 1,853,000,000 United States dollar | superseded | [clm_241C20FF1B60](/claim/clm_241C20FF1B60.md) - 2025-10-31 to 2026-01-31 | total_assets | 11,198,000,000 United States dollar | superseded | [clm_321CC9DB2BF0](/claim/clm_321CC9DB2BF0.md) - 2025-10-31 to 2026-04-30 | quarterly_research_and_development | 416,000,000 United States dollar | superseded | [clm_6FAEF4BD44F4](/claim/clm_6FAEF4BD44F4.md) - 2025-10-31 to 2026-01-31 | total_equity | 2,893,000,000 United States dollar | superseded | [clm_85C5E770EC04](/claim/clm_85C5E770EC04.md) - 2025-10-31 to 2026-01-31 | cash_and_equivalents | 1,989,000,000 United States dollar | superseded | [clm_ACFBB745C9FF](/claim/clm_ACFBB745C9FF.md) - 2025-10-31 to 2026-04-30 | quarterly_net_income | 343,000,000 United States dollar | superseded | [clm_E1B9E61986FF](/claim/clm_E1B9E61986FF.md) - 2025-11-20 to 2026-02-23 | shares_outstanding | 212,000,000 shares | superseded | [clm_750ACE54780C](/claim/clm_750ACE54780C.md) ## 2026 - 2026-01-22 | restructuring | Worldwide restructuring plan ending sales and marketing optimization; about 1,000 job cuts. | valid | [clm_F535014B05F6](/claim/clm_F535014B05F6.md) - 2026-01-31 to 2026-04-30 | total_equity | 3,045,000,000 United States dollar | superseded | [clm_22447571A96C](/claim/clm_22447571A96C.md) - 2026-01-31 to 2026-04-30 | total_assets | 12,467,000,000 United States dollar | superseded | [clm_27AD968590D2](/claim/clm_27AD968590D2.md) - 2026-01-31 | net_income | 1,124,000,000 United States dollar | valid | [clm_953794064058](/claim/clm_953794064058.md) - 2026-01-31 | operating_income | 1,578,000,000 United States dollar | valid | [clm_9C5626258931](/claim/clm_9C5626258931.md) - 2026-01-31 to 2026-04-30 | cash_and_equivalents | 2,249,000,000 United States dollar | superseded | [clm_B5FC1927A713](/claim/clm_B5FC1927A713.md) - 2026-01-31 | revenue | 7,206,000,000 United States dollar | valid | [clm_B7BB1AE9D637](/claim/clm_B7BB1AE9D637.md) - 2026-01-31 | research_and_development | 1,643,000,000 United States dollar | valid | [clm_D732600A15E0](/claim/clm_D732600A15E0.md) - 2026-02-23 to 2026-05-21 | shares_outstanding | 211,000,000 shares | superseded | [clm_36534B4429BE](/claim/clm_36534B4429BE.md) - 2026-04-30 to 2026-07-31 | total_assets | 11,932,000,000 United States dollar | superseded | [clm_2CA4BA779E72](/claim/clm_2CA4BA779E72.md) - 2026-04-30 to 2026-07-31 | quarterly_net_income | 491,000,000 United States dollar | superseded | [clm_46236E3280B3](/claim/clm_46236E3280B3.md) - 2026-04-30 to 2026-07-31 | quarterly_revenue | 1,934,000,000 United States dollar | superseded | [clm_46A1D59618CD](/claim/clm_46A1D59618CD.md) - 2026-04-30 to 2026-07-31 | quarterly_research_and_development | 421,000,000 United States dollar | superseded | [clm_4AB899B2E352](/claim/clm_4AB899B2E352.md) - 2026-04-30 to 2026-07-31 | quarterly_operating_income | 541,000,000 United States dollar | superseded | [clm_D4A85F603B83](/claim/clm_D4A85F603B83.md) - 2026-04-30 to 2026-07-31 | total_equity | 3,189,000,000 United States dollar | superseded | [clm_DC7555A73254](/claim/clm_DC7555A73254.md) - 2026-04-30 to 2026-07-31 | cash_and_equivalents | 2,671,000,000 United States dollar | superseded | [clm_FFDC3FE5B706](/claim/clm_FFDC3FE5B706.md) - 2026-05-21 to 2026-08-21 | shares_outstanding | 211,000,000 shares | superseded | [clm_4F408DAF9089](/claim/clm_4F408DAF9089.md) - 2026-05-28 | agreement | MaintainX Inc. | valid | [clm_2FE66EF5383C](/claim/clm_2FE66EF5383C.md) - 2026-07-31 | quarterly_operating_income | 599,000,000 United States dollar | valid | [clm_102F08DF3851](/claim/clm_102F08DF3851.md) - 2026-07-31 | total_equity | 3,383,000,000 United States dollar | valid | [clm_4A106D922A93](/claim/clm_4A106D922A93.md) - 2026-07-31 | quarterly_research_and_development | 464,000,000 United States dollar | valid | [clm_4D4DBA8278A1](/claim/clm_4D4DBA8278A1.md) - 2026-07-31 | quarterly_revenue | 2,046,000,000 United States dollar | valid | [clm_5F1499E944DF](/claim/clm_5F1499E944DF.md) - 2026-07-31 | total_assets | 12,983,000,000 United States dollar | valid | [clm_63BC1BD44A6A](/claim/clm_63BC1BD44A6A.md) - 2026-07-31 | cash_and_equivalents | 4,098,000,000 United States dollar | valid | [clm_8186F477EF0C](/claim/clm_8186F477EF0C.md) - 2026-07-31 | quarterly_net_income | 492,000,000 United States dollar | valid | [clm_8A6E2EF58A6D](/claim/clm_8A6E2EF58A6D.md) - 2026-08-21 | shares_outstanding | 209,000,000 shares | valid | [clm_5CF5D744E39E](/claim/clm_5CF5D744E39E.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.